1
|
Potvin D, D'Angelo P, Bennett S, Jankicevic J, Bissonnette R. Adaptive designs in dermatology clinical trials: Current status and future perspectives. J Eur Acad Dermatol Venereol 2024. [PMID: 38619384 DOI: 10.1111/jdv.20030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2023] [Accepted: 03/11/2024] [Indexed: 04/16/2024]
Abstract
Current drug development strategies present many challenges that can impede drug approval by regulatory agencies. Alternative study models, such as adaptive trial designs, have recently sparked interest, as they provide a flexible and more efficient approach in conducting clinical trials. Adaptive trial designs offer several potential benefits over traditional randomized controlled trials, which include decrease in costs, reduced clinical development time and limiting exposure of patients to potentially ineffective treatments allowing completion of studies with fewer patients. This article explores the current use of adaptive trial designs in non-oncologic skin diseases and highlights the most common types of adaptive designs used in the field. We also review the operational challenges and statistical considerations associated with such designs and propose clinical development strategies to successfully implement adaptive designs. The article also proposes instances where adaptive trial designs are particularly beneficial, and other situations where they may not be very useful.
Collapse
Affiliation(s)
- D Potvin
- Innovaderm Research Inc, Montreal, Quebec, Canada
| | - P D'Angelo
- Innovaderm Research Inc, Montreal, Quebec, Canada
| | - S Bennett
- Innovaderm Research Inc, Montreal, Quebec, Canada
| | - J Jankicevic
- Innovaderm Research Inc, Montreal, Quebec, Canada
| | | |
Collapse
|
2
|
Amaducci S, Colonna N, Cosentino L, Cristallo S, Finocchiaro P, Krtička M, Massimi C, Mastromarco M, Mazzone A, Maugeri EA, Mengoni A, Roederer IU, Straniero O, Valenta S, Vescovi D, Aberle O, Alcayne V, Andrzejewski J, Audouin L, Babiano-Suarez V, Bacak M, Barbagallo M, Bennett S, Berthoumieux E, Billowes J, Bosnar D, Brown A, Busso M, Caamaño M, Caballero-Ontanaya L, Calviño F, Calviani M, Cano-Ott D, Casanovas A, Cerutti F, Chiaveri E, Cortés G, Cortés-Giraldo MA, Damone LA, Davies PJ, Diakaki M, Dietz M, Domingo-Pardo C, Dressler R, Ducasse Q, Dupont E, Durán I, Eleme Z, Fernández-Domínguez B, Ferrari A, Furman V, Göbel K, Garg R, Gawlik-Ramięga A, Gilardoni S, Gonçalves IF, González-Romero E, Guerrero C, Gunsing F, Harada H, Heinitz S, Heyse J, Jenkins DG, Junghans A, Käppeler F, Kadi Y, Kimura A, Knapová I, Kokkoris M, Kopatch Y, Kurtulgil D, Ladarescu I, Lederer-Woods C, Leeb H, Lerendegui-Marco J, Lonsdale SJ, Macina D, Manna A, Martínez T, Masi A, Mastinu P, Mendoza E, Michalopoulou V, Milazzo PM, Mingrone F, Moreno-Soto J, Musumarra A, Negret A, Nolte R, Ogállar F, Oprea A, Patronis N, Pavlik A, Perkowski J, Petrone C, Piersanti L, Pirovano E, Porras I, Praena J, Quesada JM, Ramos-Doval D, Rauscher T, Reifarth R, Rochman D, Rubbia C, Sabaté-Gilarte M, Saxena A, Schillebeeckx P, Schumann D, Sekhar A, Smith AG, Sosnin NV, Sprung P, Stamatopoulos A, Tagliente G, Tain JL, Tarifeño-Saldivia A, Tassan-Got L, Thomas T, Torres-Sánchez P, Tsinganis A, Ulrich J, Urlass S, Vannini G, Variale V, Vaz P, Ventura A, Vlachoudis V, Vlastou R, Wallner A, Woods PJ, Wright T, Žugec P. Measurement of the ^{140}Ce(n,γ) Cross Section at n_TOF and Its Astrophysical Implications for the Chemical Evolution of the Universe. Phys Rev Lett 2024; 132:122701. [PMID: 38579210 DOI: 10.1103/physrevlett.132.122701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Revised: 11/09/2023] [Accepted: 01/31/2024] [Indexed: 04/07/2024]
Abstract
^{140}Ce(n,γ) is a key reaction for slow neutron-capture (s-process) nucleosynthesis due to being a bottleneck in the reaction flow. For this reason, it was measured with high accuracy (uncertainty ≈5%) at the n_TOF facility, with an unprecedented combination of a high purity sample and low neutron-sensitivity detectors. The measured Maxwellian averaged cross section is up to 40% higher than previously accepted values. Stellar model calculations indicate a reduction around 20% of the s-process contribution to the Galactic cerium abundance and smaller sizeable differences for most of the heavier elements. No variations are found in the nucleosynthesis from massive stars.
Collapse
Affiliation(s)
- S Amaducci
- INFN Laboratori Nazionali del Sud, Catania, Italy
| | - N Colonna
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Italy
| | - L Cosentino
- INFN Laboratori Nazionali del Sud, Catania, Italy
| | - S Cristallo
- Istituto Nazionale di Astrofisica - Osservatorio Astronomico d'Abruzzo, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, Italy
| | | | - M Krtička
- Charles University, Prague, Czech Republic
| | - C Massimi
- Istituto Nazionale di Fisica Nucleare, Sezione di Bologna, Italy
- Dipartimento di Fisica e Astronomia, Università di Bologna, Italy
| | - M Mastromarco
- European Organization for Nuclear Research (CERN), Switzerland
| | - A Mazzone
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Italy
- Consiglio Nazionale delle Ricerche, Bari, Italy
| | - E A Maugeri
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | - A Mengoni
- Istituto Nazionale di Fisica Nucleare, Sezione di Bologna, Italy
- Agenzia nazionale per le nuove tecnologie, l'energia e lo sviluppo economico sostenibile (ENEA), Italy
| | - I U Roederer
- Department of Physics, North Carolina State University, Raleigh, Norh Carolina 27695, USA
- Department of Astronomy, University of Michigan, Ann Arbor, Michigan 48109, USA
- Joint Institute for Nuclear Astrophysics-Center for the Evolution of the Elements (JINA-CEE), USA
| | - O Straniero
- Istituto Nazionale di Astrofisica - Osservatorio Astronomico d'Abruzzo, Italy
- INFN Sezione Napoli, Napoli, Italy
| | - S Valenta
- Charles University, Prague, Czech Republic
| | - D Vescovi
- Istituto Nazionale di Astrofisica - Osservatorio Astronomico d'Abruzzo, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, Italy
| | - O Aberle
- European Organization for Nuclear Research (CERN), Switzerland
| | - V Alcayne
- Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Spain
| | | | - L Audouin
- Institut de Physique Nucléaire, CNRS-IN2P3, Univ. Paris-Sud, Université Paris-Saclay, F-91406 Orsay Cedex, France
| | - V Babiano-Suarez
- Instituto de Física Corpuscular, CSIC - Universidad de Valencia, Spain
| | - M Bacak
- European Organization for Nuclear Research (CERN), Switzerland
- TU Wien, Atominstitut, Stadionallee 2, 1020 Wien, Austria
- CEA Irfu, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - M Barbagallo
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Italy
- European Organization for Nuclear Research (CERN), Switzerland
| | - S Bennett
- University of Manchester, United Kingdom
| | - E Berthoumieux
- CEA Irfu, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - J Billowes
- University of Manchester, United Kingdom
| | - D Bosnar
- Department of Physics, Faculty of Science, University of Zagreb, Zagreb, Croatia
| | - A Brown
- University of York, United Kingdom
| | - M Busso
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, Italy
- Dipartimento di Fisica e Geologia, Università di Perugia, Italy
| | - M Caamaño
- IGFAE-Universidade de Santiago de Compostela, Spain
| | | | - F Calviño
- Universitat Politècnica de Catalunya, Spain
| | - M Calviani
- European Organization for Nuclear Research (CERN), Switzerland
| | - D Cano-Ott
- Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Spain
| | | | - F Cerutti
- European Organization for Nuclear Research (CERN), Switzerland
| | - E Chiaveri
- European Organization for Nuclear Research (CERN), Switzerland
- University of Manchester, United Kingdom
| | - G Cortés
- Universitat Politècnica de Catalunya, Spain
| | | | - L A Damone
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Italy
- Dipartimento Interateneo di Fisica, Università degli Studi di Bari, Italy
| | - P J Davies
- University of Manchester, United Kingdom
| | - M Diakaki
- European Organization for Nuclear Research (CERN), Switzerland
- National Technical University of Athens, Greece
| | - M Dietz
- School of Physics and Astronomy, University of Edinburgh, United Kingdom
| | - C Domingo-Pardo
- Instituto de Física Corpuscular, CSIC - Universidad de Valencia, Spain
| | - R Dressler
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | - Q Ducasse
- Physikalisch-Technische Bundesanstalt (PTB), Bundesallee 100, 38116 Braunschweig, Germany
| | - E Dupont
- CEA Irfu, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - I Durán
- IGFAE-Universidade de Santiago de Compostela, Spain
| | - Z Eleme
- University of Ioannina, Greece
| | | | - A Ferrari
- European Organization for Nuclear Research (CERN), Switzerland
| | - V Furman
- Affiliated with an institute or an international laboratory covered by a cooperation agreement with CERN
| | - K Göbel
- Goethe University Frankfurt, Germany
| | - R Garg
- School of Physics and Astronomy, University of Edinburgh, United Kingdom
| | | | - S Gilardoni
- European Organization for Nuclear Research (CERN), Switzerland
| | | | - E González-Romero
- Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Spain
| | | | - F Gunsing
- CEA Irfu, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - H Harada
- Japan Atomic Energy Agency (JAEA), Tokai-Mura, Japan
| | - S Heinitz
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | - J Heyse
- European Commission, Joint Research Centre (JRC), Geel, Belgium
| | | | - A Junghans
- Helmholtz-Zentrum Dresden-Rossendorf, Germany
| | - F Käppeler
- Karlsruhe Institute of Technology, Campus North, IKP, 76021 Karlsruhe, Germany
| | - Y Kadi
- European Organization for Nuclear Research (CERN), Switzerland
| | - A Kimura
- Japan Atomic Energy Agency (JAEA), Tokai-Mura, Japan
| | - I Knapová
- Charles University, Prague, Czech Republic
| | - M Kokkoris
- National Technical University of Athens, Greece
| | - Y Kopatch
- Affiliated with an institute or an international laboratory covered by a cooperation agreement with CERN
| | | | - I Ladarescu
- Instituto de Física Corpuscular, CSIC - Universidad de Valencia, Spain
| | - C Lederer-Woods
- School of Physics and Astronomy, University of Edinburgh, United Kingdom
| | - H Leeb
- TU Wien, Atominstitut, Stadionallee 2, 1020 Wien, Austria
| | | | - S J Lonsdale
- School of Physics and Astronomy, University of Edinburgh, United Kingdom
| | - D Macina
- European Organization for Nuclear Research (CERN), Switzerland
| | - A Manna
- Istituto Nazionale di Fisica Nucleare, Sezione di Bologna, Italy
- Dipartimento di Fisica e Astronomia, Università di Bologna, Italy
| | - T Martínez
- Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Spain
| | - A Masi
- European Organization for Nuclear Research (CERN), Switzerland
| | - P Mastinu
- INFN Laboratori Nazionali di Legnaro, Italy
| | - E Mendoza
- Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Spain
| | - V Michalopoulou
- European Organization for Nuclear Research (CERN), Switzerland
- National Technical University of Athens, Greece
| | - P M Milazzo
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, Italy
| | - F Mingrone
- European Organization for Nuclear Research (CERN), Switzerland
| | - J Moreno-Soto
- CEA Irfu, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - A Musumarra
- Istituto Nazionale di Fisica Nucleare, Sezione di Catania, Italy
- Department of Physics and Astronomy, University of Catania, Italy
| | - A Negret
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Romania
| | - R Nolte
- Physikalisch-Technische Bundesanstalt (PTB), Bundesallee 100, 38116 Braunschweig, Germany
| | | | - A Oprea
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Romania
| | | | - A Pavlik
- University of Vienna, Faculty of Physics, Vienna, Austria
| | | | - C Petrone
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Romania
| | - L Piersanti
- Istituto Nazionale di Astrofisica - Osservatorio Astronomico d'Abruzzo, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, Italy
| | - E Pirovano
- Physikalisch-Technische Bundesanstalt (PTB), Bundesallee 100, 38116 Braunschweig, Germany
| | | | | | | | - D Ramos-Doval
- Institut de Physique Nucléaire, CNRS-IN2P3, Univ. Paris-Sud, Université Paris-Saclay, F-91406 Orsay Cedex, France
| | - T Rauscher
- Department of Physics, University of Basel, Switzerland
- Centre for Astrophysics Research, University of Hertfordshire, United Kingdom
| | | | - D Rochman
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | - C Rubbia
- European Organization for Nuclear Research (CERN), Switzerland
| | - M Sabaté-Gilarte
- European Organization for Nuclear Research (CERN), Switzerland
- Universidad de Sevilla, Spain
| | - A Saxena
- Bhabha Atomic Research Centre (BARC), India
| | - P Schillebeeckx
- European Commission, Joint Research Centre (JRC), Geel, Belgium
| | - D Schumann
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | - A Sekhar
- University of Manchester, United Kingdom
| | - A G Smith
- University of Manchester, United Kingdom
| | - N V Sosnin
- University of Manchester, United Kingdom
| | - P Sprung
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | | | - G Tagliente
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Italy
| | - J L Tain
- Instituto de Física Corpuscular, CSIC - Universidad de Valencia, Spain
| | | | - L Tassan-Got
- European Organization for Nuclear Research (CERN), Switzerland
- Institut de Physique Nucléaire, CNRS-IN2P3, Univ. Paris-Sud, Université Paris-Saclay, F-91406 Orsay Cedex, France
- National Technical University of Athens, Greece
| | - Th Thomas
- Goethe University Frankfurt, Germany
| | | | - A Tsinganis
- European Organization for Nuclear Research (CERN), Switzerland
| | - J Ulrich
- Paul Scherrer Institut (PSI), Villigen, Switzerland
| | - S Urlass
- European Organization for Nuclear Research (CERN), Switzerland
- Helmholtz-Zentrum Dresden-Rossendorf, Germany
| | - G Vannini
- Istituto Nazionale di Fisica Nucleare, Sezione di Bologna, Italy
- Dipartimento di Fisica e Astronomia, Università di Bologna, Italy
| | - V Variale
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, Italy
| | - P Vaz
- Instituto Superior Técnico, Lisbon, Portugal
| | - A Ventura
- Istituto Nazionale di Fisica Nucleare, Sezione di Bologna, Italy
| | - V Vlachoudis
- European Organization for Nuclear Research (CERN), Switzerland
| | - R Vlastou
- National Technical University of Athens, Greece
| | - A Wallner
- Australian National University, Canberra, Australia
| | - P J Woods
- School of Physics and Astronomy, University of Edinburgh, United Kingdom
| | - T Wright
- University of Manchester, United Kingdom
| | - P Žugec
- Department of Physics, Faculty of Science, University of Zagreb, Zagreb, Croatia
| |
Collapse
|
3
|
Johnson LF, Kassanjee R, Folb N, Bennett S, Boulle A, Levitt NS, Curran R, Bobrow K, Roomaney RA, Bachmann MO, Fairall LR. A model-based approach to estimating the prevalence of disease combinations in South Africa. BMJ Glob Health 2024; 9:e013376. [PMID: 38388163 PMCID: PMC10884267 DOI: 10.1136/bmjgh-2023-013376] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2023] [Accepted: 11/12/2023] [Indexed: 02/24/2024] Open
Abstract
BACKGROUND The development of strategies to better detect and manage patients with multiple long-term conditions requires estimates of the most prevalent condition combinations. However, standard meta-analysis tools are not well suited to synthesising heterogeneous multimorbidity data. METHODS We developed a statistical model to synthesise data on associations between diseases and nationally representative prevalence estimates and applied the model to South Africa. Published and unpublished data were reviewed, and meta-regression analysis was conducted to assess pairwise associations between 10 conditions: arthritis, asthma, chronic obstructive pulmonary disease (COPD), depression, diabetes, HIV, hypertension, ischaemic heart disease (IHD), stroke and tuberculosis. The national prevalence of each condition in individuals aged 15 and older was then independently estimated, and these estimates were integrated with the ORs from the meta-regressions in a statistical model, to estimate the national prevalence of each condition combination. RESULTS The strongest disease associations in South Africa are between COPD and asthma (OR 14.6, 95% CI 10.3 to 19.9), COPD and IHD (OR 9.2, 95% CI 8.3 to 10.2) and IHD and stroke (OR 7.2, 95% CI 5.9 to 8.4). The most prevalent condition combinations in individuals aged 15+ are hypertension and arthritis (7.6%, 95% CI 5.8% to 9.5%), hypertension and diabetes (7.5%, 95% CI 6.4% to 8.6%) and hypertension and HIV (4.8%, 95% CI 3.3% to 6.6%). The average numbers of comorbidities are greatest in the case of COPD (2.3, 95% CI 2.1 to 2.6), stroke (2.1, 95% CI 1.8 to 2.4) and IHD (1.9, 95% CI 1.6 to 2.2). CONCLUSION South Africa has high levels of HIV, hypertension, diabetes and arthritis, by international standards, and these are reflected in the most prevalent condition combinations. However, less prevalent conditions such as COPD, stroke and IHD contribute disproportionately to the multimorbidity burden, with high rates of comorbidity. This modelling approach can be used in other settings to characterise the most important disease combinations and levels of comorbidity.
Collapse
Affiliation(s)
- Leigh F Johnson
- Centre for Infectious Disease Epidemiology and Research (CIDER), University of Cape Town, Cape Town, South Africa
| | - Reshma Kassanjee
- Centre for Infectious Disease Epidemiology and Research (CIDER), University of Cape Town, Cape Town, South Africa
| | | | | | - Andrew Boulle
- Centre for Infectious Disease Epidemiology and Research (CIDER), University of Cape Town, Cape Town, South Africa
- Department of Health, Western Cape Provincial Government, Cape Town, South Africa
| | - Naomi S Levitt
- Department of Medicine, University of Cape Town, Cape Town, South Africa
| | - Robyn Curran
- Knowledge Translation Unit, University of Cape Town, Cape Town, Western Cape, South Africa
| | - Kirsty Bobrow
- Department of Medicine, University of Cape Town, Cape Town, South Africa
| | - Rifqah A Roomaney
- Burden of Disease Research Unit, South African Medical Research Council, Cape Town, Western Cape, South Africa
| | - Max O Bachmann
- Norwich Medical School, University of East Anglia, Faculty of Medicine and Health Sciences, Norwich, UK
| | - Lara R Fairall
- Knowledge Translation Unit, University of Cape Town, Cape Town, Western Cape, South Africa
- King's Global Health Institute, King's College London, London, UK
| |
Collapse
|
4
|
Craig J, Sriram A, Sadoff R, Bennett S, Bahati F, Beauvais W. Correction: Behavior-change interventions to improve antimicrobial stewardship in human health, animal health, and livestock agriculture: A systematic review. PLOS Glob Public Health 2024; 4:e0002930. [PMID: 38315672 PMCID: PMC10843131 DOI: 10.1371/journal.pgph.0002930] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2024]
Abstract
[This corrects the article DOI: 10.1371/journal.pgph.0001526.].
Collapse
|
5
|
Bennett S, Verry C, Kaza E, Miao X, Berbeco RI, Sudhyadhom A. Theranostic Nanoparticle Uptake in Patient Brain Tumors as Quantified by MP2RAGE T1 Mapping. Int J Radiat Oncol Biol Phys 2023; 117:S32. [PMID: 37784476 DOI: 10.1016/j.ijrobp.2023.06.296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Modern radiation therapy techniques provide effective treatments for solid tumors, but there remain challenges with delivering high doses to elusive tumors without causing toxicity to surrounding normal tissue. Pre-clinical trials have demonstrated the theranostic properties of a recently developed gadolinium-based nanoparticle (Gd-NP). The first in-human clinical trial was conducted to assess the safety and dose tolerance of intravenous Gd-NPs in combination with whole brain radiotherapy and showed favorable results, including a significant correlation between tumor uptake and therapeutic response. The second, double-blinded, in-human clinical trial is underway in the US and aims to evaluate if brain-directed stereotactic radiation in conjunction with NPs will improve local tumor control compared to radiation alone. The current work investigates uptake patterns in brain tumors of 23 patients as quantified by magnetization prepared 2 rapid gradient echo (MP2RAGE) T1 mapping. MATERIALS/METHODS A phantom containing eight vials of NP-saline solutions at varying concentrations was created to examine the relationship between NP concentration and longitudinal relaxation (T1, in seconds). This relationship is known as relaxivity and is dependent on the contrast agent, field strength and T1 mapping sequence. A 3T MAGNETOM Vida scanner and MP2RAGE sequence were used to image the phantom and MP2RAGE T1 maps were calculated using Bloch equations (QMRLab software). Relaxivity was determined and applied to 23 patient T1 maps (pre- and post- Gd-NP administration) to calculate uptake on an individual tumor basis. Theranostic NP uptake was calculated for every voxel in each of 129 brain metastases and examined for patterns in quantity and distribution. RESULTS Average individual tumor uptake ranged from 0.02-0.12 mg/ml, where average overall uptake was equal to 0.05 mg/ml. A relationship between tumor diameter and mean NP concentration was observed and best represented by a power-based curve (R2 = 0.92). In contrast, patients with suspected placebo administration appeared to have no uptake and therefore no relationship with tumor diameter. The distribution of NP concentration within the tumor was also examined; on average, linear uptake profiles through tumor centroids (ant-post, left-right) demonstrated roughly gaussian patterns of uptake with lower concentrations at the tumor edges and higher concentrations at the tumor center. This pattern indicates robust tumor penetration and may have implications for amplifying radiation dose to hypoxic tumors. CONCLUSION Gd-NP uptake in brain metastases can be quantified using MP2RAGE T1 mapping. Uptake was determined for each voxel in each tumor volume, where a gaussian pattern of spatial concentrations was observed. This analysis procedure will be applied to the full data set, when available, to evaluate the impact of NP uptake (in conjunction with radiation therapy) within individual patients and individual tumors.
Collapse
Affiliation(s)
- S Bennett
- Department of Radiation Oncology, Brigham and Women's Hospital, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA
| | - C Verry
- Centre Hospitalier Universitaire Grenoble-Alpes, Maquis du Grésivaudan, 38700 La Tronche, France
| | - E Kaza
- Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA
| | - X Miao
- Siemens Medical Solutions USA Inc, Malvern, PA
| | - R I Berbeco
- Department of Radiation Oncology, Brigham and Women's Hospital, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA
| | - A Sudhyadhom
- Department of Radiation Oncology, Brigham and Women's Hospital, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA
| |
Collapse
|
6
|
Johnson AG, Linde L, Payne AB, Ali AR, Aden V, Armstrong B, Armstrong B, Auche S, Bayoumi NS, Bennett S, Boulton R, Chang C, Collingwood A, Cueto K, Davidson SL, Du Y, Fleischauer A, Force V, Frank D, Hamilton R, Harame K, Harrington P, Hicks L, Hodis JD, Hoskins M, Jones A, Kanishka FNU, Kaur R, Kirkendall S, Khan SI, Klioueva A, Link-Gelles R, Lyons S, Mansfield J, Markelz A, Masarik J, Mendoza E, Morris K, Omoike E, Paritala S, Patel K, Pike M, Pompa XP, Praetorius K, Rammouni N, Razzaghi H, Riggs A, Shi M, Sigalo N, Stanislawski E, Tilakaratne BP, Turner KA, Wiedeman C, Silk BJ, Scobie HM. Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged ≥65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months - 20 U.S. Jurisdictions, September 18, 2022-April 1, 2023. MMWR Morb Mortal Wkly Rep 2023; 72:667-669. [PMID: 37319029 PMCID: PMC10328470 DOI: 10.15585/mmwr.mm7224a6] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/17/2023]
|
7
|
Olsen KS, Jadi O, Dexheimer S, Bortone DS, Vensko SP, Bennett S, Tang H, Diiorio M, Saran T, Dingfelder D, Zhu Q, Wang Y, Haiman CA, Pooler L, Sheng X, Webb A, Pasquini MC, McCarthy PL, Spellman SR, Weimer E, Hahn T, Sucheston-Campbell L, Armistead PM, Vincent BG. Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT. Blood Adv 2023; 7:1635-1649. [PMID: 36477467 PMCID: PMC10182302 DOI: 10.1182/bloodadvances.2022008863] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2022] [Revised: 11/07/2022] [Accepted: 11/16/2022] [Indexed: 12/13/2022] Open
Abstract
T-cell responses to minor histocompatibility antigens (mHAs) mediate graft-versus-leukemia (GVL) effects and graft-versus-host disease (GVHD) in allogeneic hematopoietic cell transplantation. Therapies that boost T-cell responses improve allogeneic hematopoietic cell transplant (alloHCT) efficacy but are limited by concurrent increases in the incidence and severity of GVHD. mHAs with expression restricted to hematopoietic tissue (GVL mHAs) are attractive targets for driving GVL without causing GVHD. Prior work to identify mHAs has focused on a small set of mHAs or population-level single-nucleotide polymorphism-association studies. We report the discovery of a large set of novel GVL mHAs based on predicted immunogenicity, tissue expression, and degree of sharing among donor-recipient pairs (DRPs) in the DISCOVeRY-BMT data set of 3231 alloHCT DRPs. The total number of predicted mHAs varied by HLA allele, and the total number and number of each class of mHA significantly differed by recipient genomic ancestry group. From the pool of predicted mHAs, we identified the smallest sets of GVL mHAs needed to cover 100% of DRPs with a given HLA allele. We used mass spectrometry to search for high-population frequency mHAs for 3 common HLA alleles. We validated 24 predicted novel GVL mHAs that are found cumulatively within 98.8%, 60.7%, and 78.9% of DRPs within DISCOVeRY-BMT that express HLA-A∗02:01, HLA-B∗35:01, and HLA-C∗07:02, respectively. We confirmed the immunogenicity of an example novel mHA via T-cell coculture with peptide-pulsed dendritic cells. This work demonstrates that the identification of shared mHAs is a feasible and promising technique for expanding mHA-targeting immunotherapeutics.
Collapse
Affiliation(s)
- Kelly S. Olsen
- Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC
- Department of Microbiology and Immunology, UNC School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC
| | - Othmane Jadi
- Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC
| | - Sarah Dexheimer
- Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC
| | - Dante S. Bortone
- Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC
| | - Steven P. Vensko
- Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC
| | - Sarah Bennett
- Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC
- Department of Microbiology and Immunology, UNC School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC
| | - Hancong Tang
- College of Pharmacy, The Ohio State University, Columbus, OH
| | - Marisa Diiorio
- Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC
| | - Tanvi Saran
- Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC
| | - David Dingfelder
- Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC
| | - Qianqian Zhu
- Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY
| | - Yiwen Wang
- Quantitative Sciences Unit, Department of Medicine, Stanford University, Palo Alto, CA
| | - Christopher A. Haiman
- Department of Preventive Medicine, University of Southern California, Los Angeles, CA
| | - Loreall Pooler
- The Center for Genetic Epidemiology, University of South California, Los Angeles, CA
| | - Xin Sheng
- Department of Preventive Medicine, University of Southern California, Los Angeles, CA
| | - Amy Webb
- Department of Biomedical Informatics, The Ohio State University, Columbus, OH
| | - Marcelo C. Pasquini
- Center for International Blood and Marrow Transplant Research and Medical College of Wisconsin, Milwaukee, WI
| | - Philip L. McCarthy
- Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY
| | - Stephen R. Spellman
- National Marrow Donor Program, Center for International Blood and Marrow Transplant Research, Minneapolis, MN
| | - Eric Weimer
- Department of Pathology & Laboratory Medicine, UNC School of Medicine, Chapel Hill, NC
| | - Theresa Hahn
- Department of Cancer Prevention & Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY
| | - Lara Sucheston-Campbell
- College of Pharmacy, The Ohio State University, Columbus, OH
- College of Veterinary Medicine, The Ohio State University, Columbus, OH
| | - Paul M. Armistead
- Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC
- Division of Hematology, Department of Medicine, UNC School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC
| | - Benjamin G. Vincent
- Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC
- Department of Microbiology and Immunology, UNC School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC
- Division of Hematology, Department of Medicine, UNC School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC
- Computational Medicine Program, UNC School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC
- Curriculum in Bioinformatics and Computational Biology, UNC School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC
| |
Collapse
|
8
|
Craig J, Sriram A, Sadoff R, Bennett S, Bahati F, Beauvais W. Behavior-change interventions to improve antimicrobial stewardship in human health, animal health, and livestock agriculture: A systematic review. PLOS Glob Public Health 2023; 3:e0001526. [PMID: 37155592 PMCID: PMC10166487 DOI: 10.1371/journal.pgph.0001526] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/22/2023] [Accepted: 04/16/2023] [Indexed: 05/10/2023]
Abstract
Antimicrobial resistance (AMR) is an economic, food security, and global health threat accelerated by a multitude of factors including the overuse and misuse of antimicrobials in the human health, animal health, and agriculture sectors. Given the rapid emergence and spread of AMR and the relative lack of development of new antimicrobials or alternative therapies, there is a need to develop and implement non-pharmaceutical AMR mitigation policies and interventions that improve antimicrobial stewardship (AMS) practices across all sectors where antimicrobials are used. We conducted a systematic literature review per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines to identify peer-reviewed studies that described behavior-change interventions that aimed to improve AMS and/or reduce inappropriate antimicrobial use (AMU) among human health, animal health, and livestock agriculture stakeholders. We identified 301 total publications- 11 in the animal health sector and 290 in the human health sector-and assessed described interventions using metrics across five thematic areas- (1) AMU, (2) adherence to clinical guidelines, (3) AMS, (4) AMR, and (5) clinical outcomes. The lack of studies describing the animal health sector precluded a meta-analysis. Variation across intervention type, study type, and outcome precluded a meta-analysis for studies describing the human health sector; however, a summary descriptive analysis was conducted. Among studies in the human health sector, 35.7% reported significant (p<0.05) pre- to post-intervention decreases in AMU, 73.7% reported significant improvements in adherence of antimicrobial therapies to clinical guidelines, 45% demonstrated significant improvements in AMS practices, 45.5% reported significant decreases in the proportion of isolates that were resistant to antibiotics or the proportion of patients with drug-resistant infections across 17 antimicrobial-organism combinations. Few studies reported significant changes in clinical outcomes. We did not identify any overarching intervention type nor characteristics associated with successful improvement in AMS, AMR, AMU, adherence, nor clinical outcomes.
Collapse
Affiliation(s)
- Jessica Craig
- Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, United States of America
| | | | - Rachel Sadoff
- Mailman School of Public Health, Columbia University, New York, NY, United States of America
| | | | - Felix Bahati
- King’s College London, London, United Kingdom
- KEMRI Wellcome Trust Research Programme, Health Services Research Unit, Nairobi, Kenya
- Department of Environmental Health and Disease Control, College of Health Sciences, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
| | - Wendy Beauvais
- Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, United States of America
| |
Collapse
|
9
|
Bloom PA, Bartlett E, Kathios N, Algharazi S, Siegelman M, Shen F, Beresford L, DiMaggio-Potter ME, Singh A, Bennett S, Natarajan N, Lee H, Sajid S, Joyce E, Fischman R, Hutchinson S, Pan S, Tottenham N, Aly M. Effects of familiar music exposure on deliberate retrieval of remote episodic and semantic memories in healthy aging adults. Memory 2023; 31:428-456. [PMID: 36651851 DOI: 10.1080/09658211.2023.2166078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Familiar music facilitates memory retrieval in adults with dementia. However, mechanisms behind this effect, and its generality, are unclear because of a lack of parallel work in healthy aging. Exposure to familiar music enhances spontaneous recall of memories directly cued by the music, but it is unknown whether such effects extend to deliberate recall more generally - e.g., to memories not directly linked to the music being played. It is also unclear whether familiar music boosts recall of specific episodes versus more generalised semantic memories, or whether effects are driven by domain-general mechanisms (e.g., improved mood). In a registered report study, we examined effects of familiar music on deliberate recall in healthy adults ages 65-80 years (N = 75) by presenting familiar music from earlier in life, unfamiliar music, and non-musical audio clips across three sessions. After each clip, we assessed free recall of remote memories for pre-selected events. Contrary to our hypotheses, we found no effects of music exposure on recall of prompted events, though familiar music evoked spontaneous memories most often. These results suggest that effects of familiar music on recall may be limited to memories specifically evoked in response to the music (Preprint and registered report protocol at https://osf.io/kjnwd/).
Collapse
Affiliation(s)
| | - Ella Bartlett
- Barnard College of Columbia University, New York, NY, USA
| | | | | | | | - Fan Shen
- Columbia University, New York, NY, USA
| | | | | | | | - Sarah Bennett
- Teachers College, Columbia University, New York, NY, USA
| | | | | | | | - Erin Joyce
- Teachers College, Columbia University, New York, NY, USA
| | | | | | - Sophie Pan
- Barnard College of Columbia University, New York, NY, USA
| | | | | |
Collapse
|
10
|
Soeters HM, Doshi RH, Fleming M, Adegoke OJ, Ajene U, Aksnes BN, Bennett S, Blau EF, Carlton JG, Clements S, Conklin L, Dahlke M, Duca LM, Feldstein LR, Gidudu JF, Grant G, Hercules M, Igboh LS, Ishizumi A, Jacenko S, Kerr Y, Konne NM, Kulkarni S, Kumar A, Lafond KE, Lam E, Longley AT, McCarron M, Namageyo-Funa A, Ortiz N, Patel JC, Perry RT, Prybylski D, Reddi P, Salman O, Sciarratta CN, Shragai T, Siddula A, Sikare E, Tchoualeu DD, Traicoff D, Tuttle A, Victory KR, Wallace A, Ward K, Wong MKA, Zhou W, Schluter WW, Fitter DL, Mounts A, Bresee JS, Hyde TB. CDC's COVID-19 International Vaccine Implementation and Evaluation Program and Lessons from Earlier Vaccine Introductions. Emerg Infect Dis 2022; 28:S208-S216. [PMID: 36502382 DOI: 10.3201/eid2813.212123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
The US Centers for Disease Control and Prevention (CDC) supports international partners in introducing vaccines, including those against SARS-CoV-2 virus. CDC contributes to the development of global technical tools, guidance, and policy for COVID-19 vaccination and has established its COVID-19 International Vaccine Implementation and Evaluation (CIVIE) program. CIVIE supports ministries of health and their partner organizations in developing or strengthening their national capacities for the planning, implementation, and evaluation of COVID-19 vaccination programs. CIVIE's 7 priority areas for country-specific technical assistance are vaccine policy development, program planning, vaccine confidence and demand, data management and use, workforce development, vaccine safety, and evaluation. We discuss CDC's work on global COVID-19 vaccine implementation, including priorities, challenges, opportunities, and applicable lessons learned from prior experiences with Ebola, influenza, and meningococcal serogroup A conjugate vaccine introductions.
Collapse
|
11
|
Elfassy M, Gewarges M, Bagga A, Basuita M, Bennett S, Janusonis I, McLean B, Nadarajah S, Osei-Yeboah C, Rosh J, Sklar J, Tanaka D, Teitelbaum D, Scales D, Luk A, Dorian P. ARE BEST PRACTICE GUIDELINES INFORMING WITHDRAWAL OF LIFE SUSTAINING THERAPY FOLLOWED AFTER CARDIAC ARREST? Can J Cardiol 2022. [DOI: 10.1016/j.cjca.2022.08.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
12
|
Bennett S, Nevison S, Sahak H, Holzapfel E, Aves T, Dorian P. TREADMILL STRESS TEST VENTILATORY PATTERN USING A WEARABLE DEVICE AS AN ADDITIONAL MARKER FOR CV DISEASE. Can J Cardiol 2022. [DOI: 10.1016/j.cjca.2022.08.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
13
|
Toon J, Geneva M, Sharpe P, Lavin J, Bennett S, Avery A. Weight loss outcomes achieved by adults accessing an online programme offered as part of Public Health England's 'Better Health' campaign. BMC Public Health 2022; 22:1456. [PMID: 35907834 PMCID: PMC9339188 DOI: 10.1186/s12889-022-13847-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2022] [Accepted: 07/21/2022] [Indexed: 11/24/2022] Open
Abstract
Effective use of health technology may offer a scalable solution to the obesity pandemic. Online digital programmes provide a convenient and flexible way for more people to access regular support. This service evaluation aims to determine whether adults accessing an online weight management programme via a national campaign are successful in losing weight. Data was analysed for adults registering with Slimming World’s online programme using a discounted membership offered as part of PHE’s ‘Better Health’ campaign between July and December 2020. Last-weight carried forward was used to calculate weight outcomes for participants who had the opportunity to complete 12-weeks and recorded ≥ one weight besides baseline. Engagement was determined using number of online weekly weights recorded with high engagers having weight data for ≥ 9 occasions. Socioeconomic status was assessed using postcode data. Resubscription and uploaded weight data were used to determine numbers who continued beyond the offer period. Twenty-seven thousand two hundred forty-eight adults (5.3% males) with mean age 41.0 ± 11.4 years met inclusion criteria. Mean baseline BMI was 33.4 ± 6.8 kg/m2 (29.2% 30–34.9, 18.3% 35–39.9 and 15.1% > 40 kg/m2). Mean weight loss at 12 weeks was 2.7 (± 3) kg representing a mean loss of 3% (± 3.1) body weight with 42.3% achieving ≥ 3% and 22.1% weight loss ≥ 5%. Median number of weigh-ins was six. Men had greater weight losses compared to women (p < 0.001). High engagers, both men and women, achieved greater weight losses (p < 0.001). Absolute weight loss was associated with joining BMI (rs = -0.15, p < 0.001) but for % weight change only small differences were seen (max effect size = 0.03) with no differences in weight change for high engagers between different baseline BMI categories (p > 0.05). 30.9% were in the lowest two IMD quintiles and absolute and percentage weight change did not differ across deprivation quintiles (p > 0.05). 34.9% continued to access the online support after the offer period. This service evaluation shows that an online programme, offered as part of a national campaign, can offer effective support to a large number of people with different starting BMIs and from different socioeconomic backgrounds. An increased level of engagement leads to better weight losses.
Collapse
Affiliation(s)
- Josef Toon
- Nutrition, Health & Research Team, Slimming World, Alfreton, UK
| | - Martina Geneva
- Nutrition, Health & Research Team, Slimming World, Alfreton, UK
| | - Paul Sharpe
- Nutrition, Health & Research Team, Slimming World, Alfreton, UK
| | - Jacquie Lavin
- Nutrition, Health & Research Team, Slimming World, Alfreton, UK
| | - Sarah Bennett
- Nutrition, Health & Research Team, Slimming World, Alfreton, UK
| | - Amanda Avery
- Nutrition, Health & Research Team, Slimming World, Alfreton, UK. .,Division of Food, Nutrition & Dietetics, University of Nottingham, Nottingham, UK.
| |
Collapse
|
14
|
Abstract
ABSTRACT The harms of implicit bias in clinical settings are acknowledged but poorly understood and difficult to overcome. We discuss how structural components of electronic medical record (EMR) user interfaces may contribute to sex and gender-based discrimination against patients via constant, duplicative presentation of stigmatizing sexually transmitted infection (STI) data irrespective of clinical significance. Via comparison with symbolism and representative quotes in Hawthorne's 1850 novel The Scarlet Letter, we propose a metaphor to examine how EMRs function as a platform for moral judgment, which may display an indelible "scarlet letter" for pregnant patients with STI history. We consider whether current depictions of STIs in EMRs are structurally unjust and may contribute to biased treatment by directing attention to violations of hegemonic sex/gender norms regarding sexual behavior and thus triggering moral judgments of maternal fitness. We conclude with recommendations for how to address these challenges to improve ethical stewardship of sensitive sexual/reproductive health data.
Collapse
Affiliation(s)
- Sarah Bennett
- Department of Obstetrics and Gynecology, Magee Womens Hospital, University of Pittsburgh Medical Center
| | | | | | - Marielle Gross
- Department of Obstetrics and Gynecology, Magee Womens Hospital, University of Pittsburgh Medical Center
| |
Collapse
|
15
|
Jones B, Bennett S, Larsson I, Zangi H, Boström C, Van der Elst K, Fayet F, Fusama M, Herrero Manso MDC, Hoeper JR, Kukkurainen ML, Kwok SK, Frãzao-Mateus E, Minnock P, Nava T, Pavic Nikolic M, Primdahl J, Rawat R, Schoenfelder M, Sierakowska M, Voshaar M, Wammervold E, van Tubergen A, Ndosi M. Disseminating and assessing implementation of the EULAR recommendations for patient education in inflammatory arthritis: a mixed-methods study with patients' perspectives. RMD Open 2022; 8:rmdopen-2022-002256. [PMID: 35459751 PMCID: PMC9036425 DOI: 10.1136/rmdopen-2022-002256] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2022] [Accepted: 03/29/2022] [Indexed: 01/11/2023] Open
Abstract
Objectives To explore patients’ agreement and reasons for agreement or disagreement with the EULAR recommendations for patient education (PE) for people with inflammatory arthritis (IA). Methods This mixed-method survey collected data using snowball sampling. The survey had been translated into 20 languages by local healthcare professionals, researchers and patient research partners. It explored the degree to which patients with IA agreed with each recommendation for PE (0=do not agree at all and 10=agree completely) and their rationale for their agreement level in free text questions. Descriptive statistics summarised participants’ demographics and agreement levels. Qualitative content analysis was used to analyse the free text data. Sixteen subcategories were developed, describing the reasons for agreement or disagreement with the recommendations, which constituted the categories. Results The sample comprised 2779 participants (79% female), with a mean (SD) age 55.1 (13.1) years and disease duration 17.1 (13.3) years. Participants strongly agreed with most recommendations (median 10 (IQR: 9–10) for most recommendations). Reasons for agreement with the recommendations included the benefit of using PE to facilitate collaborative care and shared decision making, the value of flexible and tailored PE, and the value of gaining support from other patients. Reasons for disagreement included lack of resources for PE, not wanting information to be tailored by healthcare professionals and a reluctance to use telephone-based PE. Conclusion The EULAR recommendations for PE have been disseminated among patients with IA. Overall, agreement levels were very high, suggesting that they reflect patients’ preferences for engaging in collaborative clinical care and using PE to facilitate and supplement their own understanding of IA. Reasons for not completely agreeing with the recommendations can inform implementation strategies and education of healthcare professionals.
Collapse
Affiliation(s)
- Bethan Jones
- School of Health and Social Wellbeing, University of the West of England, Bristol, UK.,School of Healthcare Sciences, Cardiff University, Cardiff, UK
| | - Sarah Bennett
- School of Health and Social Wellbeing, University of the West of England, Bristol, UK.,Translational Health Sciences, University of Bristol, Bristol, UK
| | - Ingrid Larsson
- School of Health and Welfare, Halmstad University, Halmstad, Sweden.,Spenshult Research and Development Centre, Halmstad, Sweden
| | - Heidi Zangi
- National Advisory Unit for Rehabilitation in Rheumatology, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.,Faculty of Health, VID Specialized University, Oslo, Norway
| | - Carina Boström
- Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institute, Stockholm, Sweden
| | | | - Françoise Fayet
- Department of Rheumatology, Clermont-Ferrand Teaching Hospital, Clermont-Ferrand, France
| | - Mie Fusama
- School of Nursing, Takarazuka University, Osaka, Japan
| | | | - Juliana Rachel Hoeper
- Center for Health Economics Research Hannover (CHERH), Leibniz University Hanover, Hannover, Germany.,Clinic for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany
| | | | - Suet Kei Kwok
- Department of Rheumatology and Clinical Immunology Unit, Grantham Hospital, Hong Kong, China
| | | | - Patricia Minnock
- Rheumatic Musculoskeletal Disease Unit, Our Lady's Hospice & Care Services, Dublin, Ireland
| | - Tiziana Nava
- Department of Translational Medicine and Surgery, University of Milan-Bicocca, Milano, Italy
| | - Milena Pavic Nikolic
- Department of Rheumatology, Division of Internal Medicine, University Medical Centre Ljubljana, Kamnik, Slovenia
| | - Jette Primdahl
- Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.,Danish Hospital for Rheumatic Diseases, University Hospital of Southern Denmark, Sønderborg, Denmark
| | - Roopa Rawat
- Joint Disease Clinic, Indian Spinal Injuries Centre, New Delhi, India
| | - Mareen Schoenfelder
- Österreichische Rheumaliga, Vienna, Austria.,Sprachinstitut TREFFPUNKT, Bamberg, Germany
| | - Matylda Sierakowska
- Department of Integrated Medical Care, Medical University of Bialystok, Bialystok, Poland
| | - Marieke Voshaar
- Department of Pharmacy, Radboud University Medical Center for Infectious Diseases, Nijmegen, The Netherlands
| | | | - Astrid van Tubergen
- CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, Netherlands.,Department of Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands
| | - Mwidimi Ndosi
- School of Health and Social Wellbeing, University of the West of England, Bristol, UK .,Academic Rheumatology Unit, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK
| |
Collapse
|
16
|
Bekker LG, Garrett N, Goga A, Fairall L, Reddy T, Yende-Zuma N, Kassanjee R, Collie S, Sanne I, Boulle A, Seocharan I, Engelbrecht I, Davies MA, Champion J, Chen T, Bennett S, Mametja S, Semenya M, Moultrie H, de Oliveira T, Lessells RJ, Cohen C, Jassat W, Groome M, Von Gottberg A, Le Roux E, Khuto K, Barouch D, Mahomed H, Wolmarans M, Rousseau P, Bradshaw D, Mulder M, Opie J, Louw V, Jacobson B, Rowji P, Peter JG, Takalani A, Odhiambo J, Mayat F, Takuva S, Corey L, Gray GE. Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study. Lancet 2022; 399:1141-1153. [PMID: 35305740 PMCID: PMC8930006 DOI: 10.1016/s0140-6736(22)00007-1] [Citation(s) in RCA: 42] [Impact Index Per Article: 21.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/17/2021] [Revised: 11/18/2021] [Accepted: 12/13/2021] [Indexed: 12/30/2022]
Abstract
BACKGROUND We aimed to assess the effectiveness of a single dose of the Ad26.COV2.S vaccine (Johnson & Johnson) in health-care workers in South Africa during two waves of the South African COVID-19 epidemic. METHODS In the single-arm, open-label, phase 3B implementation Sisonke study, health-care workers aged 18 years and older were invited for vaccination at one of 122 vaccination sites nationally. Participants received a single dose of 5 × 1010 viral particles of the Ad26.COV2.S vaccine. Vaccinated participants were linked with their person-level data from one of two national medical insurance schemes (scheme A and scheme B) and matched for COVID-19 risk with an unvaccinated member of the general population. The primary outcome was vaccine effectiveness against severe COVID-19, defined as COVID-19-related admission to hospital, hospitalisation requiring critical or intensive care, or death, in health-care workers compared with the general population, ascertained 28 days or more after vaccination or matching, up to data cutoff. This study is registered with the South African National Clinical Trial Registry, DOH-27-022021-6844, ClinicalTrials.gov, NCT04838795, and the Pan African Clinical Trials Registry, PACTR202102855526180, and is closed to accrual. FINDINGS Between Feb 17 and May 17, 2021, 477 102 health-care workers were enrolled and vaccinated, of whom 357 401 (74·9%) were female and 119 701 (25·1%) were male, with a median age of 42·0 years (33·0-51·0). 215 813 vaccinated individuals were matched with 215 813 unvaccinated individuals. As of data cutoff (July 17, 2021), vaccine effectiveness derived from the total matched cohort was 83% (95% CI 75-89) to prevent COVID-19-related deaths, 75% (69-82) to prevent COVID-19-related hospital admissions requiring critical or intensive care, and 67% (62-71) to prevent COVID-19-related hospitalisations. The vaccine effectiveness for all three outcomes were consistent across scheme A and scheme B. The vaccine effectiveness was maintained in older health-care workers and those with comorbidities including HIV infection. During the course of the study, the beta (B.1.351) and then the delta (B.1.617.2) SARS-CoV-2 variants of concerns were dominant, and vaccine effectiveness remained consistent (for scheme A plus B vaccine effectiveness against COVID-19-related hospital admission during beta wave was 62% [95% CI 42-76] and during delta wave was 67% [62-71], and vaccine effectiveness against COVID-19-related death during beta wave was 86% [57-100] and during delta wave was 82% [74-89]). INTERPRETATION The single-dose Ad26.COV2.S vaccine shows effectiveness against severe COVID-19 disease and COVID-19-related death after vaccination, and against both beta and delta variants, providing real-world evidence for its use globally. FUNDING National Treasury of South Africa, the National Department of Health, Solidarity Response Fund NPC, The Michael & Susan Dell Foundation, The Elma Vaccines and Immunization Foundation, and the Bill & Melinda Gates Foundation.
Collapse
Affiliation(s)
- Linda-Gail Bekker
- The Desmond Tutu HIV Centre, Cape Town, South Africa; University of Cape Town, Cape Town, South Africa
| | - Nigel Garrett
- Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa
| | - Ameena Goga
- HIV Prevention Research Unit, Cape Town, South Africa; Department of Paediatrics and Child Health, University of Pretoria, Pretoria, South Africa
| | - Lara Fairall
- The Desmond Tutu HIV Centre, Cape Town, South Africa; King's Global Health Institute, King's College London, London, UK
| | - Tarylee Reddy
- Biostatistics Research Unit, South African Medical Research Council, Durban, South Africa
| | - Nonhlanhla Yende-Zuma
- Nelson R Mandela School of Medicine, Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa
| | - Reshma Kassanjee
- Centre of Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, Cape Town, South Africa
| | | | - Ian Sanne
- Clinical HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Witwatersrand, South Africa; Right to Care, Houghton South Africa
| | - Andrew Boulle
- Centre of Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, Cape Town, South Africa; Western Cape Government Health, Cape Town, South Africa; Wellcome Centre for Infectious Diseases Research in Africa, Cape Town, South Africa
| | - Ishen Seocharan
- Biostatistics Research Unit, South African Medical Research Council, Durban, South Africa
| | | | - Mary-Ann Davies
- Centre of Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, Cape Town, South Africa; Western Cape Government: Health Centre for Infectious Disease Epidemiology and Research, Cape Town, South Africa
| | | | | | | | | | | | - Harry Moultrie
- Centre for Tuberculosis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
| | - Tulio de Oliveira
- KwaZulu-Natal Research Innovation, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
| | - Richard John Lessells
- KwaZulu-Natal Research Innovation, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
| | - Cheryl Cohen
- School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Witwatersrand, South Africa; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
| | - Waasila Jassat
- National Institute for Communicable Diseases, Sandringham, South Africa
| | - Michelle Groome
- School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Witwatersrand, South Africa; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, Johannesburg, South Africa
| | - Anne Von Gottberg
- Department of Pathology, Cape Town, South Africa; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Witwatersrand, South Africa; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
| | - Engelbert Le Roux
- Hutchinson Center Research Institute of South Africa (HCRISA), Chris Hani Baragwanath Academic Hospital, Soweto, South Africa
| | - Kentse Khuto
- Hutchinson Center Research Institute of South Africa (HCRISA), Chris Hani Baragwanath Academic Hospital, Soweto, South Africa
| | - Dan Barouch
- Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
| | - Hassan Mahomed
- Metro Health Services, Western Cape Government Health, Cape Town, South Africa; Division of Health Systems and Public Health, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
| | | | | | - Debbie Bradshaw
- South African Medical Research Council, Tygerberg, South Africa
| | - Michelle Mulder
- South Africa Medical Research Council, Cape Town, South Africa
| | - Jessica Opie
- University of Cape Town, Cape Town, South Africa; National Health Laboratory Service, Cape Town, South Africa
| | - Vernon Louw
- Division of Clinical Haematology, Department of Medicine, Cape Town, South Africa; Groote Schuur Hospital, Cape Town, South Africa
| | - Barry Jacobson
- Faculty of Health Sciences, and Allergy and Immunology Unit, Cape Town, South Africa
| | - Pradeep Rowji
- Neurology Association of South Africa, The Southern African Society of Thrombosis and Haemostasis, Johannesburg, South Africa
| | - Jonny G Peter
- Division of Allergy and Clinical Immunology, Cape Town, South Africa
| | - Azwi Takalani
- Hutchinson Center Research Institute of South Africa (HCRISA), Chris Hani Baragwanath Academic Hospital, Soweto, South Africa
| | - Jackline Odhiambo
- Hutchinson Center Research Institute of South Africa (HCRISA), Chris Hani Baragwanath Academic Hospital, Soweto, South Africa
| | - Fatima Mayat
- Perinatal HIV Research Unit (PHRU), Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Witwatersrand, South Africa
| | - Simbarashe Takuva
- School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - Lawrence Corey
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - Glenda E Gray
- South Africa Medical Research Council, Cape Town, South Africa.
| |
Collapse
|
17
|
Bennett S, Fliss I, Ben Said L, Malouin F, Lacasse P. Efficacy of bacteriocin-based formula for reducing staphylococci, streptococci, and total bacterial counts on teat skin of dairy cows. J Dairy Sci 2022; 105:4498-4507. [DOI: 10.3168/jds.2021-21381] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2021] [Accepted: 01/24/2022] [Indexed: 11/19/2022]
|
18
|
Babiano-Suarez V, Balibrea-Correa J, Caballero-Ontanaya L, Domingo-Pardo C, Ladarescu I, Lerendegui-Marco J, Tain JL, Calviño F, Casanovas A, Tarifeño-Saldivia A, Guerrero C, Aberle O, Alcayne V, Amaducci S, Andrzejewski J, Audouin L, Bacak M, Barbagallo M, Bennett S, Berthoumieux E, Billowes J, Bosnar D, Brown A, Busso M, Caamaño M, Calviani M, Cano-Ott D, Cerutti F, Chiaveri E, Colonna N, Cortés G, CortésGiraldo MA, Cosentino L, Cristallo S, Damone LA, Davies PJ, Diakaki M, Dietz M, Dressler R, Ducasse Q, Dupont E, Durán I, Eleme Z, Fernández-Domínguez B, Ferrari A, Finocchiaro P, Furman V, Göbel K, Garg R, Gawlik-Ramięga A, Gilardoni S, Gonçalves IF, González-Romero E, Gunsing F, Harada H, Heinitz S, Heyse J, Jenkins DG, Junghans A, Käppeler F, Kadi Y, Kimura A, Knapová I, Kokkoris M, Kopatch Y, Krtička M, Kurtulgil D, Lederer-Woods C, Leeb H, Lonsdale SJ, Macina D, Manna A, Martínez T, Masi A, Massimi C, Mastinu P, Mastromarco M, Maugeri EA, Mazzone A, Mendoza E, Mengoni A, Michalopoulou V, Milazzo PM, Mingrone F, Moreno-Soto J, Musumarra A, Negret A, Nolte R, Ogállar F, Oprea A, Patronis N, Pavlik A, Perkowski J, Persanti L, Petrone C, Pirovano E, Porras I, Praena J, Quesada JM, Ramos-Doval D, Rauscher T, Reifarth R, Rochman D, Romanets Y, Rubbia C, Sabaté-Gilarte M, Saxena A, Schillebeeckx P, Schumann D, Sekhar A, Smith AG, Sosnin NV, Sprung P, Stamatopoulos A, Tagliente G, Tassan-Got L, Thomas T, Torres-Sánchez P, Tsinganis A, Ulrich J, Urlass S, Valenta S, Vannini G, Variale V, Vaz P, Ventura A, Vescovi D, Vlachoudis V, Vlastou R, Wallner A, Woods PJ, Wright T, Žugec P. First 80Se(n, γ) cross section measurement with high resolution in the full stellar energy range 1 eV - 100 keV and its astrophysical implications for the s-process. EPJ Web Conf 2022. [DOI: 10.1051/epjconf/202226011026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Most elements heavier than iron have been generated in the stellar media by means of neutron capture reactions, approximately half are produced by the slow neutron capture or s-process. Radiative neutron capture cross section measurements are of fundamental importance for the study of this mechanism. In this contribution we present a brief summary on the measurement and results for the 80Se(n,γ) cross-section. The experiment was carried out at CERN n_TOF EAR1 via the time of flight (ToF) technique, using four C6D6 scintillation detectors with very fast response. More than a hundred new resonances have been analyzed for the first time with a high accuracy. The MACS obtained at kT = 8 keV is 36% smaller than the recommended value in KADo-NiS. Some of the astrophysical implications of this result are elucidated in this contribution.
Collapse
|
19
|
Bennett S, Tafuro J, Duckett S, Heatlie G, Kwok CS. The prevalence and significance of mitral annular disjunction on clinical outcomes in patients undergoing mitral valve surgery. Eur Heart J Cardiovasc Imaging 2022. [DOI: 10.1093/ehjci/jeab289.197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Mitral annular disjunction (MAD) is a common structural abnormality involving a distinct separation of the left atrium/mitral valve annulus and myocardium continuum. MAD is commonly associated with altered mitral valve annular dynamics, increased left ventricular and mitral valve apparatus stress and potentially life threatening arrhythmias. At present there is limited data on the prevalence and significance of MAD in patients requiring mitral valve surgery.
Purpose
To ascertain the prevalence, extent and significance of MAD on a general cohort of patients with mitral valve disease who required mitral valve surgery. Primary outcomes included: duration of surgery, need for re-do operation (any cause), neurological and gastro-intestinal complications, cardiogenic shock and mortality. These were assessed during the surgical hospitalisation period.
Methods
The local cardiothoracic database within a large tertiary centre was used to identify all patients who underwent mitral valve surgery between 2013 and 2020. From this, patients who were found to have a transthoracic echocardiogram (TTE) pre and post mitral valve surgery were included. Two experienced sonographers retrospectively reviewed and analysed each TTE. The data collected included: presence, location and extent of MAD (pre and post-surgery). The local cardiothoracic database and electronic patient records were reviewed for primary outcomes.
Results
A total of 187 patients were included (age: 65.6 ± 13.7 years, 74.2% males). The most common reason for mitral valve surgery was mitral valve prolapse (31.6%), remaining aetiologies included functional MR, ischemic MR, infective endocarditis, rheumatic mitral stenosis and congenital abnormalities. Surgical intervention included: leaflet repair ± annuloplasty ring (57.2%), bio-prosthesis (19.8%) or mechanical prosthesis (23.0%). Pre surgery, MAD was present in 32.6% of all patients and was most commonly seen in patients with mitral valve prolapse (21.3%). In patients with MAD, the averaged MAD length was 8.4 ± 3.9mm (median 7 [IQR: 5-11]). Post-surgery, MAD was only identified in 2 patients, both of whom had mitral valve repair± annuloplasty ring. As seen in Table 1, there were no significant differences in clinical outcomes in patients with or without MAD.
Conclusion
MAD is common in a cohort of patients requiring mitral valve surgery. Surgical intervention is able to correct MAD in the vast majority of patients and its presence does not affect immediate post-surgical outcomes. Abstract Table 1.
Collapse
Affiliation(s)
- S Bennett
- University Hospital of North Midlands, Stoke-on-Trent, United Kingdom of Great Britain & Northern Ireland
| | - J Tafuro
- University Hospital of North Midlands, Stoke-on-Trent, United Kingdom of Great Britain & Northern Ireland
| | - S Duckett
- University Hospital of North Midlands, Stoke-on-Trent, United Kingdom of Great Britain & Northern Ireland
| | - G Heatlie
- University Hospital of North Midlands, Stoke-on-Trent, United Kingdom of Great Britain & Northern Ireland
| | - CS Kwok
- University Hospital of North Midlands, Stoke-on-Trent, United Kingdom of Great Britain & Northern Ireland
| |
Collapse
|
20
|
Bennett S, Murphy CF, Fanning M, Reynolds JV, Doyle SL, Donohoe CL. The impact of Nutrition and Gastrointestinal Symptoms on Health-related Quality of Life in Survivorship after Oesophageal Cancer Surgery. Clinical Nutrition Open Science 2022. [DOI: 10.1016/j.nutos.2021.11.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open
|
21
|
Agustinho B, Ravelo A, Vinyard J, Lobo R, Arce-Cordero J, Monteiro H, Sarmikasoglou E, Bennett S, Johnson M, Vieira E, Stoffel C, Stocks S, Faciola A. Effects of replacing magnesium oxide with calcium-magnesium carbonate with or without sodium bicarbonate on ruminal fermentation and nutrient flow in vitro. J Dairy Sci 2022; 105:3090-3101. [DOI: 10.3168/jds.2021-20995] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2021] [Accepted: 12/06/2021] [Indexed: 11/19/2022]
|
22
|
Shiao J, Santoso A, Stuhr K, Bennett S, Holt D, Robin T, Fisher C. Gynecologic Interstitial Brachytherapy Curriculum Using a Low-Cost Phantom With Ultrasound Workshop and a Treatment Planning Workshop is Feasible and Effective. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
23
|
Chen F, Booth C, Barroso F, Bennett S, Kaya B, Win N, Telfer P. Salvage of refractory post-transfusion hyperhaemolysis by targeting hyperinflammation and macrophage activation with tocilizumab. Transfus Med 2021; 32:437-440. [PMID: 34046955 DOI: 10.1111/tme.12793] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2020] [Revised: 04/18/2021] [Accepted: 05/03/2021] [Indexed: 01/19/2023]
Affiliation(s)
- Frederick Chen
- Department of Clinical Haematology, Royal London Hospital, Barts Health NHS Trust, London, UK.,Queen Mary University London, London, UK
| | - Catherine Booth
- Department of Clinical Haematology, Royal London Hospital, Barts Health NHS Trust, London, UK.,NHS Blood and Transplant, London, UK
| | - Filipa Barroso
- Department of Clinical Haematology, Royal London Hospital, Barts Health NHS Trust, London, UK
| | - Sarah Bennett
- Department of Clinical Haematology, Royal London Hospital, Barts Health NHS Trust, London, UK
| | - Banu Kaya
- Department of Clinical Haematology, Royal London Hospital, Barts Health NHS Trust, London, UK.,Queen Mary University London, London, UK
| | - Nay Win
- NHS Blood and Transplant, Tooting Centre, London, UK
| | - Paul Telfer
- Department of Clinical Haematology, Royal London Hospital, Barts Health NHS Trust, London, UK.,Queen Mary University London, London, UK
| |
Collapse
|
24
|
Bennett S, Alexander E, Fraser H, Bowers N, Wallace A, Woodward ER, Lalloo F, Quinn AM, Huang S, Schlecht H, Evans DG. Germline FFPE inherited cancer panel testing in deceased family members: implications for clinical management of unaffected relatives. Eur J Hum Genet 2021; 29:861-871. [PMID: 33654310 PMCID: PMC8110779 DOI: 10.1038/s41431-021-00817-w] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2020] [Revised: 01/07/2021] [Accepted: 01/23/2021] [Indexed: 01/29/2023] Open
Abstract
Where previously, germline genetic testing in deceased affected relatives was not possible due to the absence of lymphocytic DNA, the North-West-Genomic-Laboratory Hub (NWGLH) has developed and validated next-generation sequencing based gene panels utilising formalin-fixed-paraffin-embedded (FFPE) tissue DNA from deceased individuals. This technology has been utilised in the clinical setting for the management of unaffected relatives seen in the Clinical Genetics Service (CGS). Here we assess the clinical impact. At the time of data collection, the NWGLH had analysed 180 FFPE tissue samples from deceased affected individuals: 134 from breast and/or ovarian cancer cases for germline variants in the BRCA1/BRCA2 genes and 46 from colorectal, gastric, ovarian and endometrial cancer cases for germline variants in a panel of 13 genes implicated in inherited colorectal cancer and gastric cancer conditions. Successful analysis was achieved in 140/180 cases (78%). In total, 29 germline pathogenic/likely pathogenic variants were identified in autosomal dominant cancer predisposition genes where the gene was pertinent to the cancer family history (including BRCA1/BRCA2, the mismatch-repair genes and APC). Of the 180 cases, the impact of the result on clinical management of unaffected relatives was known in 143 cases. Of these, the results in 54 cases (38%) directly impacted the clinical management of relatives seen by the CGS. This included changes to risk assessments, screening recommendations and the availability of predictive genetic testing to unaffected relatives. Our data demonstrate how FFPE testing in deceased relatives is an accurate and informative tool in the clinical management of patients referred to the CGS.
Collapse
Affiliation(s)
- Sarah Bennett
- Clinical Genetics Service, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK
| | - Elizabeth Alexander
- Clinical Genetics Service, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK
| | - Harry Fraser
- Northern Regional Genetic Service, Genetics Health Service New Zealand, Auckland City Hospital, Auckland, New Zealand
| | - Naomi Bowers
- North West Genomic Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK
| | - Andrew Wallace
- North West Genomic Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK
| | - Emma R. Woodward
- Clinical Genetics Service, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK ,Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Health innovation Manchester, Manchester, UK
| | - Fiona Lalloo
- Clinical Genetics Service, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK
| | - Anne Marie Quinn
- Department of Anatomic Pathology, University Hospital Galway, Galway, Ireland
| | - Shuwen Huang
- North West Genomic Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK
| | - Helene Schlecht
- North West Genomic Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK
| | - D. Gareth Evans
- Clinical Genetics Service, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK ,Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Health innovation Manchester, Manchester, UK
| |
Collapse
|
25
|
D'Souza SS, Bennett S, Kumar A, Kelnhofer LE, Weinfurter J, Suknuntha K, Coonen J, Mejia A, Simmons H, Golos T, Hematti P, Capitini CM, Reynolds MR, Slukvin II. Transplantation of T-cell receptor α/β-depleted allogeneic bone marrow in nonhuman primates. Exp Hematol 2021; 93:44-51. [PMID: 33176119 PMCID: PMC7855119 DOI: 10.1016/j.exphem.2020.09.198] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2020] [Revised: 09/24/2020] [Accepted: 09/26/2020] [Indexed: 10/23/2022]
Abstract
Allogeneic hematopoietic stem cell transplantation (alloHSCT) is a potentially curative treatment for hematologic cancers and chronic infections such as human immunodeficiency virus (HIV). Its success in these settings is attributed to the ability of engrafting immune cells to eliminate cancer cells or deplete the HIV reservoir (graft-versus-host effect [GvHE]). However, alloHSCT is commonly associated with graft-versus-host diseases (GvHDs) causing significant morbidity and mortality, thereby requiring development of novel allogeneic HSCT protocols and therapies promoting GvHE without GvHD using physiologically relevant preclinical models. Here we evaluated the outcomes of major histocompatibility complex-matched T-cell receptor α/β-depleted alloHSCT in Mauritian cynomolgus macaques (MCMs). Following T-cell receptor α/β depletion, bone marrow cells were transplanted into major histocompatibility complex-identical MCMs conditioned with total body irradiation. GvHD prophylaxis included sirolimus alone in two animals or tacrolimus with cyclophosphamide in another two animals. Posttransplant chimerism was determined by sequencing diagnostic single-nucleotide polymorphisms to quantify the amounts of donor and recipient cells present in blood. Animals treated posttransplant with sirolimus developed nearly complete chimerism with acute GvHD. In the cyclophosphamide and tacrolimus treatment group, animals developed mixed chimerism without GvHD, with long-term engraftment observed in one animal. None of the animals developed cytomegalovirus infection. These studies indicate the feasibility of alloHSCT engraftment without GvHD in an MHC-identical MCM model following complete myeloablative conditioning and anti-GvHD prophylaxis with posttransplant cyclophosphamide and tacrolimus. Further exploration of this model will provide a platform for elucidating the mechanisms of GvHD and GvHE and for testing novel alloHSCT modalities for HIV infection.
Collapse
Affiliation(s)
- Saritha S D'Souza
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI
| | - Sarah Bennett
- Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI
| | - Akhilesh Kumar
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI
| | - Laurel E Kelnhofer
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI
| | - Jason Weinfurter
- Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI
| | - Kran Suknuntha
- Department of Pathology and Laboratory Medicine, School of Medicine, University of Wisconsin-Madison, Madison, WI; Chakri Naruebodindra Medical Institute, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand
| | - Jennifer Coonen
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI
| | - Andres Mejia
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI
| | - Heather Simmons
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI
| | - Thaddeus Golos
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI; Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI; Department of Obstetrics and Gynecology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI
| | - Peiman Hematti
- Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI; Division of Hematology/Oncology/Bone Marrow Transplantation, Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, WI
| | - Christian M Capitini
- Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI
| | - Matthew R Reynolds
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI; Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI
| | - Igor I Slukvin
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI; Department of Pathology and Laboratory Medicine, School of Medicine, University of Wisconsin-Madison, Madison, WI; Department of Cell and Regenerative Biology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Madison, WI.
| |
Collapse
|
26
|
Kerr E, Malo J, Field E, Si D, Ware R, Bennett S, Lambert S. What can viral suppression indicators tell us? Monitoring progress towards improvement in HIV care for those newly diagnosed in Queensland, Australia. Int J Infect Dis 2020. [DOI: 10.1016/j.ijid.2020.09.760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
27
|
Freetly HC, Lindholm-Perry AK, Foote AP, Bennett S, Wells JE. 192 Abundance of rumen methanogens did not differ in cattle that differed in residual feed intake. J Anim Sci 2020. [DOI: 10.1093/jas/skaa278.274] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Methane represents an energetic loss, and it has been proposed that its reduction may be associated with improved feed efficiency. Rumen methanogens produce most of the methane. Forty-nine crossbred heifers were individually fed a ration that consisted of 67.75% rolled corn, 20% wet distillers grain with solubles, 8% chopped alfalfa and 4.25% mineral/vitamin/rumensin mix for 84 d. Residual feed intake was the residual of the observed – predicted FI for the multivariate regression of FI on ADG and mid-metabolic BW for the population. Six heifers with the greatest RFI (1.75 ± 0.31 kg DM/d) and 6 with least RFI (-1.48 ± 0.31 kg DM/d) were selected. Rumen fluid was sampled from a tube passed through the mouth into the rumen. Rumen fluid was flash frozen in liquid N2 and stored at -80°C. After the first collection, heifers with greater RFI were pair fed to the less RFI heifers and rumen fluid was sampled 5 wk later. DNA was isolated from the rumen fluid and primer sets targeting total methanogens, Methanomicrobiales, Methanobacteriales, Methanosarcina, Methanobacterium, Methanobrevibacter ruminantium + Mbb. Cuticularis, and Methanobrevibacter smithii + Mbb. wolinii + Mbb. thaueri + Mbb. gottschalkii + Mbb. Woesei were amplified with real-time quantitative PCR (qPCR). Standard curves were generated to quantify copy number. There were no differences in copy number for the interaction of RFI classifications and sample period for all primer sets (P > 0.18). There were no differences in (P > 0.15) in RFI classification for all qPCR primer sets. There were fewer copies for the Methanobrevibacter ruminantium + Mbb. Cuticularis qPCR for samples collected in the first week compared to the 5 wk sample (P = 0.03); however, there were no difference for collection week for the other qPCR assays (P > 0.16). USDA is an equal opportunity provider and employer.
Collapse
|
28
|
Prguda E, Burke K, Antrobus E, Bennett S. Accessibility of evidence‐based parenting programs in the community: Parents who are involved in the Criminal Justice System encounter barriers to program access. Australian Psychologist 2020. [DOI: 10.1111/ap.12405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- Emina Prguda
- Parenting and Family Support Centre, School of Psychology, The University of Queensland, Brisbane, Queensland, Australia,
| | - Kylie Burke
- Parenting and Family Support Centre, School of Psychology, The University of Queensland, Brisbane, Queensland, Australia,
| | - Emma Antrobus
- School of Social Science, The University of Queensland, Brisbane, Queensland, Australia,
| | - Sarah Bennett
- School of Social Science, The University of Queensland, Brisbane, Queensland, Australia,
| |
Collapse
|
29
|
Bennett S, Søreide K, Gholami S, Pessaux P, Teh C, Segelov E, Kennecke H, Prenen H, Myrehaug S, Callegaro D, Hallet J. Strategies for the delay of surgery in the management of resectable hepatobiliary malignancies during the COVID-19 pandemic. Curr Oncol 2020; 27:e501-e511. [PMID: 33173390 PMCID: PMC7606047 DOI: 10.3747/co.27.6785] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
Objective We aimed to review data about delaying strategies for the management of hepatobiliary cancers requiring surgery during the covid-19 pandemic. Background Given the covid-19 pandemic, many jurisdictions, to spare resources, have limited access to operating rooms for elective surgical activity, including cancer, thus forcing deferral or cancellation of cancer surgeries. Surgery for hepatobiliary cancer is high-risk and particularly resource-intensive. Surgeons must critically appraise which patients will benefit most from surgery and which ones have other therapeutic options to delay surgery. Little guidance is currently available about potential delaying strategies for hepatobiliary cancers when surgery is not possible. Methods An international multidisciplinary panel reviewed the available literature to summarize data relating to standard-of-care surgical management and possible mitigating strategies to be used as a bridge to surgery for colorectal liver metastases, hepatocellular carcinoma, gallbladder cancer, intrahepatic cholangiocarcinoma, and hilar cholangiocarcinoma. Results Outcomes of surgery during the covid-19 pandemic are reviewed. Resource requirements are summarized, including logistics and adverse effects profiles for hepatectomy and delaying strategies using systemic, percutaneous and radiation ablative, and liver embolic therapies. For each cancer type, the long-term oncologic outcomes of hepatectomy and the clinical tools that can be used to prognosticate for individual patients are detailed. Conclusions There are a variety of delaying strategies to consider if availability of operating rooms decreases. This review summarizes available data to provide guidance about possible delaying strategies depending on patient, resource, institution, and systems factors. Multidisciplinary team discussions should be leveraged to consider patient- and tumour-specific information for each individual case.
Collapse
Affiliation(s)
- S Bennett
- Canada: Department of Surgery, University of Toronto, Toronto, ON (Bennett, Callegaro, Hallet); Department of Radiation Oncology, University of Toronto, Toronto, ON (Myrehaug); Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON (Hallet)
| | - K Søreide
- Norway: Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, and Department of Clinical Medicine, University of Bergen, Bergen
| | - S Gholami
- United States: Division of Surgical Oncology, Department of Surgery, University of California, Davis, CA (Gholami); Virginia Mason Cancer Institute, Seattle, WA (Kennecke)
| | - P Pessaux
- France: Department of Surgery, Institut Hospitalo-Universitaire de Strasbourg, Strasbourg
| | - C Teh
- Philippines: Institute of Surgery, St. Luke's Medical Center, Quezon City; Department of Surgery, Makati Medical Center, Makati; and Department of General Surgery, National Kidney and Transplant Institute, Quezon City
| | - E Segelov
- Australia: Monash University and Monash Health, Melbourne
| | - H Kennecke
- United States: Division of Surgical Oncology, Department of Surgery, University of California, Davis, CA (Gholami); Virginia Mason Cancer Institute, Seattle, WA (Kennecke)
| | - H Prenen
- Belgium: Department of Oncology, University Hospital Antwerp, Antwerp
| | - S Myrehaug
- Canada: Department of Surgery, University of Toronto, Toronto, ON (Bennett, Callegaro, Hallet); Department of Radiation Oncology, University of Toronto, Toronto, ON (Myrehaug); Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON (Hallet)
| | - D Callegaro
- Canada: Department of Surgery, University of Toronto, Toronto, ON (Bennett, Callegaro, Hallet); Department of Radiation Oncology, University of Toronto, Toronto, ON (Myrehaug); Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON (Hallet)
- Italy: Department of Surgery, Fondazione irccs Istituto Nazionale Tumori, Milan
| | - J Hallet
- Canada: Department of Surgery, University of Toronto, Toronto, ON (Bennett, Callegaro, Hallet); Department of Radiation Oncology, University of Toronto, Toronto, ON (Myrehaug); Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON (Hallet)
| |
Collapse
|
30
|
Manna A, Aberle O, Alcayne V, Amaducci S, Andrzejewski J, Audouin L, Babiano VS, Bacak M, Barbagallo M, Bennett S, Berthoumieux E, Bosnar D, Brown AS, Busso M, Caamaño M, Caballero L, Calviani M, Calvi F, Cano-Ott D, Casanovas A, Cerutti F, Chiaveri E, Colonna N, Cortés GP, Cortés-Giraldo MA, Coséntino L, Cristallo S, Damone LA, Davies PJ, Diakaki M, Dietz M, Domingo-Pardo C, Dressler R, Ducasse Q, Dupont E, Durán I, Eleme Z, Fernández-Domíngez B, Ferrari A, Ferro-Goncalves I, Finocchiaro P, Furman V, Garg R, Gawlik A, Gilardoni S, Göbel K, González-Romero E, Guerrero C, Gunsing F, Heinitz S, Heyse J, Jenkins DG, Jericha E, Jiri U, Junghans A, Kadi Y, Käppeler F, Kimura A, Knapová I, Kokkoris M, Kopatch Y, Krtiička M, Kurtulgil D, Ladarescu I, Lederer-Woods C, Lerendegui-Marco J, Lonsdale SJ, Macina D, Martínez T, Masi A, Massimi C, Mastinu PF, Mastromarco M, Maugeri E, Mazzone A, Mendoza E, Mengoni A, Michalopoulou V, Milazzo PM, Millán-Callado MA, Mingrone F, Moreno-Soto J, Musumarra A, Negret A, Nolte R, Ogállar F, Oprea A, Patronis N, Pavlik A, Perkowski J, Petrone C, Piersanti L, Pirovano E, Porras I, Praena J, Quesada J, Ramos D, Reifarth R, Rochman D, Rubbia C, Sabaté-Gilarte M, Saxena A, Schillebeeckx P, Schumann D, Sekhar A, Smith A, Sosnin N, Sprung P, Stamatopoulos A, Tagliente G, Tain JL, Tarifeno-Saldivia AE, Tassan-Got L, Thomas B, Torres-Sánchez P, Tsinganis A, Urlass S, Valenta S, Vannini G, Variale V, Vaz P, Ventura A, Vescovi D, Vlachoudis V, Vlastou R, Wallner A, Woods PJ, Wright TJ, Žugec P. Setup for the measurement of the 235U(n, f) cross section relative to n-p scattering up to 1 GeV. EPJ Web Conf 2020. [DOI: 10.1051/epjconf/202023901008] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
The neutron induced fission of 235U is extensively used as a reference for neutron fluence measurements in various applications, ranging from the investigation of the biological effectiveness of high energy neutrons, to the measurement of high energy neutron cross sections of relevance for accelerator driven nuclear systems. Despite its widespread use, no data exist on neutron induced fission of 235U above 200 MeV. The neutron facility n_TOF offers the possibility to improve the situation. The measurement of 235U(n,f) relative to the differential n-p scattering cross-section, was carried out in September 2018 with the aim of providing accurate and precise cross section data in the energy range from 10 MeV up to 1 GeV. In such measurements, Recoil Proton Telescopes (RPTs) are used to measure the neutron flux while the fission events are detected and counted with dedicated detectors. In this paper the measurement campaign and the experimental set-up are illustrated.
Collapse
|
31
|
Terranova N, Aberle O, Alcayne V, Amaducci S, Andrzejewski J, Audouin L, Babiano-Suarez V, Bacak M, Barbagallo M, Bennett S, Berthoumieux E, Bosnar D, Brown AS, Busso M, Caamaño M, Caballero L, Calviani M, Calviño F, Cano-Ott D, Casanovas A, Cerutti F, Chiaveri E, Colonna N, Cortés GP, Cortés-Giraldo MA, Cosentino L, Cristallo S, Damone LA, Davies PJ, Diakaki M, Dietz M, Domingo-Pardo C, Dressler R, Ducasse Q, Dupont E, Durán I, Eleme Z, Fernández-Domíngez B, Ferrari A, Ferro-Gonçalves I, Finocchiaro P, Furman V, Garg R, Gawlik A, Gilardoni S, Göbel K, González-Romero E, Guerrero C, Gunsing F, Heinitz S, Heyse J, Jenkins DG, Jericha E, Jiri U, Junghans A, Kadi Y, Käppeler F, Kimura A, Knapová I, Kokkoris M, Kopatch Y, Krtička M, Kurtulgil D, Ladarescu I, Lederer-Woods C, Lerendegui-Marco J, Lonsdale SJ, Macina D, Manna A, Martínez T, Masi A, Massimi C, Mastinu PF, Mastromarco M, Maugeri E, Mazzone A, Mendoza E, Mengoni A, Michalopoulou V, Milazzo PM, Millán-Callado MA, Mingrone F, Moreno-Soto J, Musumarra A, Negret A, Ogállar F, Oprea A, Patronis N, Pavlik A, Perkowski J, Petrone C, Piersanti L, Pirovano E, Porras I, Praena J, Quesada JM, Doval DR, Reifarth R, Rochman D, Rubbia C, Sabaté-Gilarte M, Saxena A, Schillebeeckx P, Schumann D, Sekhar A, Smith AG, Sosnin N, Sprung P, Stamatopoulos A, Tagliente G, Tain JL, Tarifeño-Saldivia AE, Tassan-Got L, Thomas B, Torres-Sánchez P, Tsinganis A, Urlass S, Valenta S, Vannini G, Variale V, Vaz P, Ventura A, Vescovi D, Vlachoudis V, Vlastou R, Wallner A, Woods PJ, Wright TJ, Žugec P. Monte Carlo simulations and n-p differential scattering data measured with Proton Recoil Telescopes. EPJ Web Conf 2020. [DOI: 10.1051/epjconf/202023901024] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
The neutron-induced fission cross section of 235U, a standard at thermal energy and between 0.15 MeV and 200 MeV, plays a crucial role in nuclear technology applications. The long-standing need of improving cross section data above 20 MeV and the lack of experimental data above 200 MeV motivated a new experimental campaign at the n_TOF facility at CERN. The measurement has been performed in 2018 at the experimental area 1 (EAR1), located at 185 m from the neutron-producing target (the experiment is presented by A. Manna et al. in a contribution to this conference). The 235U(n,f) cross section from 20 MeV up to about 1 GeV has been measured relative to the 1H(n,n)1H reaction, which is considered the primary reference in this energy region. The neutron flux impinging on the 235U sample (a key quantity for determining the fission events) has been obtained by detecting recoil protons originating from n-p scattering in a C2H4 sample. Two Proton Recoil Telescopes (PRT), consisting of several layers of solid-state detectors and fast plastic scintillators, have been located at proton scattering angles of 25.07° and 20.32°, out of the neutron beam. The PRTs exploit the ΔE-E technique for particle identification, a basic requirement for the rejection of charged particles from neutron-induced reactions in carbon. Extensive Monte Carlo simulations were performed to characterize proton transport through the different slabs of silicon and scintillation detectors, to optimize the experimental set-up and to deduce the efficiency of the whole PRT detector. In this work we compare measured data collected with the PRTs with a full Monte Carlo simulation based on the Geant-4 toolkit.
Collapse
|
32
|
Plackett R, Kassianos AP, Kambouri M, Kay N, Mylan S, Hopwood J, Schartau P, Gray S, Timmis J, Bennett S, Valerio C, Rodrigues V, Player E, Hamilton W, Raine R, Duffy S, Sheringham J. Online patient simulation training to improve clinical reasoning: a feasibility randomised controlled trial. BMC Med Educ 2020; 20:245. [PMID: 32736583 PMCID: PMC7395338 DOI: 10.1186/s12909-020-02168-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/06/2020] [Accepted: 07/22/2020] [Indexed: 05/25/2023]
Abstract
BACKGROUND Online patient simulations (OPS) are a novel method for teaching clinical reasoning skills to students and could contribute to reducing diagnostic errors. However, little is known about how best to implement and evaluate OPS in medical curricula. The aim of this study was to assess the feasibility, acceptability and potential effects of eCREST - the electronic Clinical Reasoning Educational Simulation Tool. METHODS A feasibility randomised controlled trial was conducted with final year undergraduate students from three UK medical schools in academic year 2016/2017 (cohort one) and 2017/2018 (cohort two). Student volunteers were recruited in cohort one via email and on teaching days, and in cohort two eCREST was also integrated into a relevant module in the curriculum. The intervention group received three patient cases and the control group received teaching as usual; allocation ratio was 1:1. Researchers were blind to allocation. Clinical reasoning skills were measured using a survey after 1 week and a patient case after 1 month. RESULTS Across schools, 264 students participated (18.2% of all eligible). Cohort two had greater uptake (183/833, 22%) than cohort one (81/621, 13%). After 1 week, 99/137 (72%) of the intervention and 86/127 (68%) of the control group remained in the study. eCREST improved students' ability to gather essential information from patients over controls (OR = 1.4; 95% CI 1.1-1.7, n = 148). Of the intervention group, most (80/98, 82%) agreed eCREST helped them to learn clinical reasoning skills. CONCLUSIONS eCREST was highly acceptable and improved data gathering skills that could reduce diagnostic errors. Uptake was low but improved when integrated into course delivery. A summative trial is needed to estimate effectiveness.
Collapse
Affiliation(s)
- Ruth Plackett
- Department of Applied Health Research, University College London, 1-19 Torrington Place, London, WC1E 7HB, UK.
| | - Angelos P Kassianos
- Department of Applied Health Research, University College London, 1-19 Torrington Place, London, WC1E 7HB, UK
| | | | - Natasha Kay
- Department of Applied Health Research, University College London, 1-19 Torrington Place, London, WC1E 7HB, UK
| | - Sophie Mylan
- Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK
| | | | | | - Shani Gray
- Department of Applied Health Research, University College London, 1-19 Torrington Place, London, WC1E 7HB, UK
| | - Jessica Timmis
- Department of Applied Health Research, University College London, 1-19 Torrington Place, London, WC1E 7HB, UK
| | | | | | | | | | - Willie Hamilton
- Institute of Health Service Research, University of Exeter, Exeter, UK
| | - Rosalind Raine
- Department of Applied Health Research, University College London, 1-19 Torrington Place, London, WC1E 7HB, UK
| | - Stephen Duffy
- Wolfson Institute of Preventive Medicine, QMUL, London, UK
| | - Jessica Sheringham
- Department of Applied Health Research, University College London, 1-19 Torrington Place, London, WC1E 7HB, UK
| |
Collapse
|
33
|
Bennett S, Zangi HA, Van Tubergen A, Ndosi M. OP0157-HPR DISSEMINATION AND ASSESSING IMPLEMENTATION OF THE EULAR RECOMMENDATIONS FOR PATIENT EDUCATION FOR PEOPLE WITH INFLAMMATORY ARTHRITIS ACROSS EUROPE. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.3251] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:EULAR recommendations for patient education for people with inflammatory arthritis (IA) were published in 2015.1This is the first systematic dissemination and implementation study, reporting qualitative data identifying barriers to implementation of the recommendations.Objectives:To (i) disseminate and assess the level of acceptability and applicability of the EULAR recommendations for patient education among healthcare professionals and rheumatologists and (ii) assess potential barriers and facilitators to their application in clinical practice.Methods:This was a cross-sectional study using survey methods. Survey items were developed in English and translated into 20 different languages before being distributed to health professionals by snowball sampling using an online platform. The items covered demographic information and 10-point rating scales assessing the level of acceptability and applicability of each of the eight recommendations. In addition, textual data fields were provided to assess reasons for disagreeing and barriers to implementation of the recommendations in practice. Quantitative data were analysed descriptively with agreement and applicability levels summarised as median (IQR) scores. Textual data were analysed by content analysis and presented in themes. Finally, collaborators in each country reviewed the top barriers to implementation and proposed facilitators to implementation in their respective countries.Results:A total of 2442 responses were recorded from 23 countries, but only 1495 contained complete data. Of complete responses, 74% were women. Most of the professionals were nurses (n=640), rheumatologists (n=369) and physiotherapists (n=232).Table 1 presents the levels of agreement and applicability of the recommendations. For all recommendations, the level of agreement was high (median=10). However, the level of applicability was generally lower compared to each corresponding agreement level, especially for recommendation 6, which states that the effectiveness of patient education should be evaluated. Lack of an effective evaluation tool was the biggest barrier to implementation.Table 1.Levels of agreement and applicability of each recommendation.AgreementApplicabilityMedianIQRMedianIQRRecommendation 11010 to 1087 to 10Recommendation 21010 to 1086 to 10Recommendation 3109 to 1087 to 10Recommendation 4108 to 1075 to 10Recommendation 5108 to 1075 to 9Recommendation 6108 to 1064 to 8Recommendation 7109 to 1085 to 8Recommendation 81010 to 1085 to 8There were notable similarities between barriers and facilitators for implementation of the recommendations across countries. The 3 most common barriers to application were; (i) lack of time (ii) lack of training in how to provide patient education and (iii) not having enough staff to provide patient education. The most common facilitators were: tailoring the content and delivery of patient education to individual patients; training providers, and evaluating the effectiveness of patient education with individual patients.Conclusion:This project has disseminated the EULAR recommendations for patient education across 23 countries. There was high agreement with the recommendations among health professionals but their application to clinical practice was lower. Some barriers to application are amenable to change such as addressing training needs of health professionals and developing evaluation tools for patient education.Figure 1.Recommendations for patient education in inflammatory arthritis.1References:[1]Zangi HA, et al. EULAR recommendations for patient education for people with inflammatory arthritisAnn Rheum Dis. 2015;74:954-962.Disclosure of Interests:Sarah Bennett: None declared, Heidi A. Zangi: None declared, Astrid van Tubergen Consultant of: Novartis, Mwidimi Ndosi Grant/research support from: Bristol Myers Squibb, Consultant of: Janssen, Pfizer
Collapse
|
34
|
Bennett S, Walsh N, Moss T, Palmer S. AB1321-HPR DEVELOPING A SELF-MANAGEMENT INTERVENTION TO MANAGE JOINT HYPERMOBILITY SYNDROME AND EHLERS-DANLOS SYNDROME HYPERMOBILITY TYPE: AN ANALYSIS INFORMED BY BEHAVIOUR CHANGE THEORY. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.3646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:Joint Hypermobility Syndrome (JHS) and Ehlers-Danlos Syndrome Hypermobility Type (EDS-HT) are heritable disorders of connective tissue that can cause joint instability and pain and are associated with increased anxiety and depression. There is currently little UK guidance for supporting patients with JHS/EDS-HT1. The analysis presented here used the Behaviour Change Wheel (made up of the Theoretical Domains Framework (TDF) and Capability, Opportunity, Motivation and Behaviour (COM-B) model2) to identify possible intervention options to improve self-management in people with JHS/EDS-HT.Objectives:To determine recommendations for the components of a behaviour change intervention for people with JHS or EDS-HT.Methods:Data from: 1) A systematic review and thematic synthesis of the literature examining adults’ lived experiences of JHS/EDS3and 2) A thematic analysis of interview data where UK adults with JHS/EDS-HT (n=17, 14 women, 3 men) discussed the psychosocial impact of the condition on their lives4, were mapped onto the TDF and COM-B in a behavioural analysis. A modified Nominal Group Technique focus group (n=9, all women) explored which interventions identified by the TDF/COM-B mapping exercise were most important to them.Results:Participants prioritised a range of potential self-management interventions, including:Education: Participants wanted greater support to improve their knowledge of JHS/EDS-HT, including self-help strategies for coping with injury, fatigue and overexertion, and how to evaluate information about their condition.Training: In activity pacing, assertiveness and communication skills, and what to expect during pregnancy, when symptoms of JHS/EDS-HT can worsen.Environmental restructuring and enablement:Support from occupational therapists to maintain independence at home. Enablement of access to CBT, mindfulness and emotional support.Modelled behaviour:Positive first-person narratives that address how other patients with JHS/EDS-HT have coped with anxiety, depression, distress, fear, frustration and feelings of loss.Conclusion:This study is the first to apply theoretically-informed approaches to the management of JHS/EDS-HT. Through a modified nominal group technique, potential behaviour change interventions for addressing barriers to self-management have been prioritised. Discussion with participants indicated poor access to psychological support, occupational therapy and a lack of knowledge of JHS/EDS-HT. Future research with healthcare professional and patient stakeholder groups will further evaluate which intervention options would be most acceptable and feasible for the management of JHS/EDS-HT.References:[1]Palmer, S., Terry, R. Rimes, K.A., Clark, C., Simmonds, J. & Horwood, J. (2016). Physiotherapy management of joint hypermobility syndrome – a focus group study of patient and health professional perspectives. Physiotherapy,http://dx.doi.org/10.1016/j.physio.2015.05.001.[2]Michie, S., van Stralen, M.M. & West, R. (2011). The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implementation Science, 6(42).[3]Bennett, S.E., Walsh, N., Moss, T. and Palmer, S. (2019a) “The lived experience of joint hypermobility and Ehlers-Danlos Syndromes: A systematic review and thematic synthesis.”Physical Therapy Reviews, 24 (1-2). pp. 12-28. ISSN 1083-3196[4]Bennett, S.E., Walsh, N., Moss, T. and Palmer, S. (2019b) “Understanding the psychosocial impact of Joint Hypermobility Syndrome and Ehlers-Danlos Syndrome Hypermobility Type: A qualitative interview study.”Disability and Rehabilitation. ISSN 0963-8288Disclosure of Interests:None declared
Collapse
|
35
|
Stein A, Baker F, Larratt C, Bennett S, Harris K, Feehally J, Walls J. Correction of Metabolic Acidosis and the Protein Catabolic Rate in Pd Patients. Perit Dial Int 2020. [DOI: 10.1177/089686089401400223] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Affiliation(s)
- A. Stein
- Department of Nephrology Leicester General Hospital Leicester LE5 4PW, U.K
| | - F. Baker
- Department of Nephrology Leicester General Hospital Leicester LE5 4PW, U.K
| | - C. Larratt
- Department of Nephrology Leicester General Hospital Leicester LE5 4PW, U.K
| | - S. Bennett
- Department of Nephrology Leicester General Hospital Leicester LE5 4PW, U.K
| | - K. Harris
- Department of Nephrology Leicester General Hospital Leicester LE5 4PW, U.K
| | - J. Feehally
- Department of Nephrology Leicester General Hospital Leicester LE5 4PW, U.K
| | - J. Walls
- Department of Nephrology Leicester General Hospital Leicester LE5 4PW, U.K
| |
Collapse
|
36
|
Affiliation(s)
- A. Stein
- Department of Nephrology Leicester General Hospital Leicester LE5 4PW, United Kingdom
| | - S. Bennett
- Department of Nephrology Leicester General Hospital Leicester LE5 4PW, United Kingdom
| | - J. Feehally
- Department of Nephrology Leicester General Hospital Leicester LE5 4PW, United Kingdom
| | - J. Walls
- Department of Nephrology Leicester General Hospital Leicester LE5 4PW, United Kingdom
| |
Collapse
|
37
|
Barbagallo M, Aberle O, Alcayne V, Amaducci S, Andrzejewski J, Audouin L, Babiano-Suarez V, Bacak M, Bennett S, Berthoumieux E, Bosnar D, Brown AS, Busso M, Caamaño M, Caballero L, Calviani M, Calviño F, Cano-Ott D, Casanovas A, Cerutti F, Chiaveri E, Colonna N, Cortés GP, Cortés-Giraldo MA, Cosentino L, Cristallo S, Damone LA, Davies PJ, Diakaki M, Dietz M, Domingo-Pardo C, Dressler R, Ducasse Q, Dupont E, Durán I, Eleme Z, Fernández-Domíngez B, Ferrari A, Ferro-Gonçalves I, Finocchiaro P, Furman V, Garg R, Gawlik A, Gilardoni S, Göbel K, González-Romero E, Guerrero C, Gunsing F, Heinitz S, Heyse J, Jenkins DG, Jericha E, Jiri U, Junghans A, Kadi Y, Käppeler F, Kimura A, Knapová I, Kokkoris M, Kopatch Y, Krtička M, Kurtulgil D, Ladarescu I, Lederer-Woods C, Lerendegui-Marco J, Lonsdale SJ, Macina D, Manna A, Martínez T, Masi A, Massimi C, Mastinu PF, Mastromarco M, Maugeri E, Mazzone A, Mendoza E, Mengoni A, Michalopoulou V, Milazzo PM, Millán-Callado MA, Mingrone F, Moreno-Soto J, Musumarra A, Negret A, Ogállar F, Oprea A, Patronis N, Pavlik A, Perkowski J, Petrone C, Piersanti L, Pirovano E, Porras I, Praena J, Quesada JM, Ramos Doval D, Reifarth R, Rochman D, Rubbia C, Sabaté- Gilarte M, Saxena A, Schillebeeckx P, Schumann D, Sekhar A, Smith AG, Sosnin N, Sprung P, Stamatopoulos A, Tagliente G, Tain JL, Tarifeño-Saldivia AE, Tassan-Got L, Thomas B, Torres-Sánchez P, Tsinganis A, Urlass S, Valenta S, Vannini G, Variale V, Vaz P, Ventura A, Vescovi D, Vlachoudis V, Vlastou R, Wallner A, Woods PJ, Wright TJ, Žugec P. Measurement of the energy-differential cross-section of the 12C(n,p) 12B and 12C(n,d) 11B reactions at the n_TOF facility at CERN. EPJ Web Conf 2020. [DOI: 10.1051/epjconf/202023901045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Although the 12C(n,p)12B and 12C(n,d)11B reactions are of interest in several fields of basic and applied Nuclear Physics the present knowledge of these two cross-sections is far from being accurate and reliable, with both evaluations and data showing sizable discrepancies. As part of the challenging n_TOF program on (n,cp) nuclear reactions study, the energy differential cross-sections of the 12C(n,p)12B and 12C(n,d)11 B reactions have been measured at CERN from the reaction thresholds up to 30 MeV neutron energy. Both measurements have been recently performed at the long flight-path (185 m) experimental area of the n_TOF facility at CERN using a pure (99.95%) rigid graphite target and two silicon telescopes. In this paper an overview of the experiment is presented together with a few preliminary results.
Collapse
|
38
|
Chiaveri E, Aberle O, Alcayne V, Amaducci S, Andrzejewski J, Audouin L, Babiano-Suarez V, Bacak M, Barbagallo M, Bennett S, Berthoumieux E, Bosnar D, Brown A, Busso M, Caamaño M, Caballero L, Calviani M, Calviño F, Cano-Ott D, Casanovas A, Cerutti F, Colonna N, Cortés G, Cortés-Giraldo M, Cosentino L, Cristallo S, Damone L, Davies P, Diakaki M, Dietz M, Domingo-Pardo C, Dressler R, Ducasse Q, Dupont E, Durán I, Eleme Z, Fernández-Domíngez B, Ferrari A, Ferro-Gonçalves I, Finocchiaro P, Furman V, Garg R, Gawlik A, Gilardoni S, Göbel K, González-Romero E, Guerrero C, Gunsing F, Heinitz S, Heyse J, Jenkins D, Jericha E, Jiri U, Junghans A, Kadi Y, Käppeler F, Kimura A, Knapová I, Kokkoris M, Kopatch Y, Krtička M, Kurtulgil D, Ladarescu I, Lederer-Woods C, Lerendegui-Marco J, Lonsdale SJ, Macina D, Manna A, Martínez T, Masi A, Massimi C, Mastinu P, Mastromarco M, Maugeri E, Mazzone A, Mendoza E, Mengoni A, Michalopoulou V, Milazzo P, Millán-Callado M, Mingrone F, Moreno-Soto J, Musumarra A, Negret A, Ogállar F, Oprea A, Patronis N, Pavlik A, Perkowski J, Petrone C, Piersanti L, Pirovano E, Porras I, Praena J, Quesada J, Ramos Doval D, Reifarth R, Rochman D, Rubbia C, Sabaté-Gilarte M, Saxena A, Schillebeeckx P, Schumann D, Sekhar A, Smith A, Sosnin N, Sprung P, Stamatopoulos A, Tagliente G, Tain J, Tarifeño-Saldivia A, Tassan-Got L, Thomas B, Torres-Sánchez P, Tsinganis A, Urlass S, Valenta S, Vannini G, Variale V, Vaz P, Ventura A, Vescovi D, Vlachoudis V, Vlastou R, Wallner A, Woods P, Wright T, Žugec P. Status and perspectives of the neutron time-of-flight facility n_TOF at CERN. EPJ Web Conf 2020. [DOI: 10.1051/epjconf/202023917001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Since the start of its operation in 2001, based on an idea of Prof. Carlo Rubbia [1], the neutron time of-flight facility of CERN, n_TOF, has become one of the most forefront neutron facilities in the world for wide-energy spectrum neutron cross section measurements. Thanks to the combination of excellent neutron energy resolution and high instantaneous neutron flux available in the two experimental areas, the second of which has been constructed in 2014, n_TOF is providing a wealth of new data on neutron-induced reactions of interest for nuclear astrophysics, advanced nuclear technologies and medical applications. The unique features of the facility will continue to be exploited in the future, to perform challenging new measurements addressing the still open issues and long-standing quests in the field of neutron physics. In this document the main characteristics of the n_TOF facility and their relevance for neutron studies in the different areas of research will be outlined, addressing the possible future contribution of n_TOF in the fields of nuclear astrophysics, nuclear technologies and medical applications. In addition, the future perspectives of the facility will be described including the upgrade of the spallation target, the setup of an imaging installation and the construction of a new irradiation area.
Collapse
|
39
|
Michalopoulou V, Stamatopoulos A, Vlastou R, Kokkoris M, Tsinganis A, Diakaki M, Eleme Z, Patronis N, Heyse J, Schillebeeckx P, Tassan-Got L, Barbagallo M, Colonna N, Urlass S, Macina D, Chiaveri E, Aberle O, Alcayne V, Amaducci S, Andrzejewski J, Audouin L, Babiano-Suarez V, Bacak M, Bennett S, Berthoumieux E, Bosnar D, Brown AS, Busso M, Caamaño M, Caballero L, Calviani M, Calviño F, Cano-Ott D, Casanovas A, Cerutti F, Cortés GP, Cortés-Giraldo MA, Cosentino L, Cristallo S, Damone LA, Davies PJ, Dietz M, Domingo-Pardo C, Dressler R, Ducasse Q, Dupont E, Durán I, Femández-Domíngez B, Ferrari A, Ferro-Gonçalves I, Finocchiaro P, Furman V, Garg R, Gawlik A, Gilardoni S, Göbel K, González-Romero E, Guerrero C, Gunsing F, Heinitz S, Jenkins DG, Jericha E, Jiri U, Junghans A, Kadi Y, Käppeler F, Kimura A, Knapová I, Kopatch Y, Krtiička M, Kurtulgil D, Ladarescu I, Lederer-Woods C, Lerendegui-Marco J, Lonsdale SJ, Manna A, Martínez T, Masi A, Massimi C, Mastinu PF, Mastromarco M, Maugeri E, Mazzone A, Mendoza E, Mengoni A, Milazzo PM, Millán-Callado MA, Mingrone F, Moreno-Soto J, Musumarra A, Negret A, Ogállar F, Oprea A, Pavlik A, Perkowski J, Petrone C, Piersanti L, Pirovano E, Porras I, Praena J, Quesada JM, Ramos Doval D, Reifarth R, Rochman D, Rubbia C, Sabaté-Gilarte M, Saxena A, Schumann D, Sekhar A, Smith AG, Sosnin N, Sprung P, Tagliente G, Tain JL, Tarifeño-Saldivia AE, Thomas B, Torres-Sánchez P, Valenta S, Vannini G, Variale V, Vaz P, Ventura A, Vescovi D, Vlachoudis V, Wallner A, Woods PJ, Wright TJ, Žugec P. First results of the 230Th(n,f) cross section measurements at the CERN n_TOF facility. EPJ Web Conf 2020. [DOI: 10.1051/epjconf/202023905004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
The study of neutron-induced reactions on actinides is of considerable importance for the design of advanced nuclear systems and alternative fuel cycles. Specifically, 230Th is produced from the α-decay of 234U as a byproduct of the 232Th/233U fuel cycle, thus the accurate knowledge of its fission cross section is strongly required. However, few experimental datasets exist in literature with large deviations among them, covering the energy range between 0.2 to 25 MeV. In addition, the study of the 230Th(n,f) cross-section is of great interest in the research on the fission process related to the structure of the fission barriers. Previous measurements have revealed a large resonance at En=715 keV and additional fine structures, but with high discrepancies among the cross-section values of these measurements. This contribution presents preliminary results of the 230Th(n,f) cross-section measurements at the CERN n_TOF facility. The high purity targets of the natural, but very rare isotope 230Th, were produced at JRC-Geel in Belgium. The measurements were performed at both experimental areas (EAR-1 and EAR-2) of the n_TOF facility, covering a very broad energy range from thermal up to at least 100 MeV. The experimental setup was based on Micromegas detectors with the 235U(n,f) and 238U(n,f) reaction cross-sections used as reference.
Collapse
|
40
|
Mengoni A, Damone L, Barbagallo M, Aberle O, Alcayne V, Amaducci S, Andrzejewski J, Audouin L, Babiano-Suarez V, Bacak M, Bennett S, Berthoumieux E, Bosnar D, Brown A, Busso M, Caamaño M, Caballero L, Calviani M, Calviño F, Cano-Ott D, Casanovas A, Cerutti F, Chiaveri E, Colonna N, Cortés G, Cortés-Giraldo M, Cosentino L, Cristallo S, Davies P, Diakaki M, Dietz M, Domingo-Pardo C, Dressler R, Ducasse Q, Dupont E, Durán I, Eleme Z, Fernández-Domíngez B, Ferrari A, Ferro-Gonçalves I, Finocchiaro P, Furman V, Garg R, Gawlik A, Gilardoni S, Göbel K, González-Romero E, Guerrero C, Gunsing F, Heinitz S, Heyse J, Jenkins D, Jericha E, Jiri U, Junghans A, Kadi Y, Käppeler F, Kimura A, Knapová I, Kokkoris M, Kopatch Y, Krtička M, Kurtulgil D, Ladarescu I, Lederer-Woods C, Lerendegui-Marco J, Lonsdale SJ, Macina D, Manna A, Martínez T, Masi A, Massimi C, Mastinu P, Mastromarco M, Maugeri E, Mazzone A, Mendoza E, Michalopoulou V, Milazzo P, Millán-Callado M, Mingrone F, Moreno-Soto J, Musumarra A, Negret A, Ogállar F, Oprea A, Patronis N, Pavlik A, Perkowski J, Petrone C, Piersanti L, Pirovano E, Porras I, Praena J, Quesada J, Doval DR, Reifarth R, Rochman D, Rubbia C, Sabaté-Gilarte M, Saxena A, Schillebeeckx P, Schumann D, Sekhar A, Smith A, Sosnin N, Sprung P, Stamatopoulos A, Tagliente G, Tain J, Tarifeño-Saldivia A, Tassan-Got L, Thomas B, Torres-Sánchez P, Tsinganis A, Urlass S, Valenta S, Vannini G, Variale V, Vaz P, Ventura A, Vescovi D, Vlachoudis V, Vlastou R, Wallner A, Woods P, Wright T, Žugec P. New reaction rates for the destruction of 7Be during big bang nucleosynthesis measured at CERN/n_TOF and their implications on the cosmological lithium problem. EPJ Web Conf 2020. [DOI: 10.1051/epjconf/202023907001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
New measurements of the7Be(n,α)4He and7Be(n,p)7Li reaction cross sections from thermal to keV neutron energies have been recently performed at CERN/n_TOF. Based on the new experimental results, astrophysical reaction rates have been derived for both reactions, including a proper evaluation of their uncertainties in the thermal energy range of interest for big bang nucleosynthesis studies. The new estimate of the7Be destruction rate, based on these new results, yields a decrease of the predicted cosmological7Li abundance insufficient to provide a viable solution to the cosmological lithium problem.
Collapse
|
41
|
Mastromarco M, Mazzone A, Massimi C, Cristallo S, Colonna N, Aberle O, Alcayne V, Amaducci S, Andrzejewski J, Audouin L, Babiano-Suarez V, Bacak M, Barbagallo M, Bennett S, Berthoumieux E, Bosnar D, Brown AS, Busso M, Caamaño M, Caballero L, Calviani M, Calviño F, Cano-Ott D, Casanovas A, Cerutti F, Chiaveri E, Cortés GP, Cortés-Giraldo MA, Cosentino L, Damone LA, Davies PJ, Diakaki M, Dietz M, Domingo-Pardo C, Dressler R, Ducasse Q, Dupont E, Durán I, Eleme Z, Fernández-Domíngez B, Ferrari A, Ferro-Gonçalves I, Finocchiaro P, Furman V, Garg R, Gawlik A, Gilardoni S, Göbel K, González-Romero E, Guerrero C, Gunsing F, Heinitz S, Heyse J, Jenkins DG, Jericha E, Jiri U, Junghans A, Kadi Y, Käppeler F, Kimura A, Knapová I, Kokkoris M, Kopatch Y, Krtička M, Kurtulgil D, Ladarescu I, Lederer-Woods C, Lerendegui-Marco J, Lonsdale SJ, Macina D, Manna A, Martínez T, Masi A, Mastinu PF, Maugeri E, Mendoza E, Mengoni A, Michalopoulou V, Milazzo PM, Millán-Callado MA, Mingrone F, Moreno-Soto J, Musumarra A, Negret A, Ogállar F, Oprea A, Patronis N, Pavlik A, Perkowski J, Petrone C, Piersanti L, Pirovano E, Porras I, Praena J, Quesada JM, Doval DR, Reifarth R, Rochman D, Rubbia C, Sabaté-Gilarte M, Saxena A, Schillebeeckx P, Schumann D, Sekhar A, Smith AG, Sosnin N, Sprung P, Stamatopoulos A, Tagliente G, Tain JL, Tarifeño-Saldivia AE, Tassan-Got L, Thomas B, Torres-Sánchez P, Tsinganis A, Urlass S, Valenta S, Vannini G, Variale V, Vaz P, Ventura A, Vescovi D, Vlachoudis V, Vlastou R, Wallner A, Woods PJ, Wright TJ, Žugec P. The 154Gd neutron capture cross section measured at the n_TOF facility and its astrophysical implications. EPJ Web Conf 2020. [DOI: 10.1051/epjconf/202023907003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
The (n, γ) cross sections of the gadolinium isotopes play an important role in the study of the stellar nucleosynthesis. In particular, among the isotopes heavier than Fe, 154Gd together with 152Gd have the peculiarity to be mainly produced by the slow capture process, the so-called s-process, since they are shielded against the β-decay chains from the r-process region by their stable samarium isobars. Such a quasi pure s-process origin makes them crucial for testing the robustness of stellar models in galactic chemical evolution (GCE). According to recent models, the 154Gd and 152Gd abundances are expected to be 15-20% lower than the reference un-branched s-process 150Sm isotope. The close correlation between stellar abundances and neutron capture cross sections prompted for an accurate measurement of 154Gd cross section in order to reduce the uncertainty attributable to nuclear physics input and eventually rule out one of the possible causes of present discrepancies between observation and model predictions. To this end, the neutron capture cross section of 154Gd was measured in a wide neutron energy range (from thermal up to some keV) with high resolution in the first experimental area of the neutron time-of-flight facility n_TOF (EAR1) at CERN. In this contribution, after a brief description of the motivation and of the experimental setup used in the measurement, the preliminary results of the 154Gd neutron capture reaction as well as their astrophysical implications are presented.
Collapse
|
42
|
Eleme Z, Patronis N, Stamatopoulos A, Tsinganis A, Kokkoris M, Michalopoulou V, Diakaki M, Vlastou R, Tassan-Got L, Colonna N, Heyse J, Barbagallo M, Mastromarco M, Macina D, Chiaveri E, Aberle O, Alcayne V, Amaducci S, Andrzejewski J, Audouin L, Babiano-Suarez V, Bacak M, Bennett S, Berthoumieux E, Bosnar D, Brown AS, Busso M, Caamaño M, Caballero L, Calviani M, Calviño F, Cano-Ott D, Casanovas A, Cerutti F, Cortés GP, Cortés-Giraldo MA, Cosentino L, Cristallo S, Damone LA, Davies PJ, Dietz M, Domingo-Pardo C, Dressler R, Ducasse Q, Dupont E, Durán I, Fernández-Domíngez B, Ferrari A, Ferro-Gonçalves I, Finocchiaro P, Furman V, Garg R, Gawlik A, Gilardoni S, Göbel K, González-Romero E, Guerrero C, Gunsing F, Heinitz S, Jenkins DG, Jericha E, Jiri U, Junghans A, Kadi Y, Käppeler F, Kimura A, Knapová I, Kopatch Y, Krticˇka M, Kurtulgil D, Ladarescu I, Lederer-Woods C, Lerendegui-Marco J, Lonsdale SJ, Manna A, Martínez T, Masi A, Massimi C, Mastinu PF, Maugeri E, Mazzone A, Mendoza E, Mengoni A, Milazzo PM, Millán-Callado MA, Mingrone F, Moreno-Soto J, Musumarra A, Negret A, Ogállar F, Oprea A, Pavlik A, Perkowski J, Petrone C, Piersanti L, Pirovano E, Porras I, Praena J, Quesada JM, Ramos Doval D, Reifarth R, Rochman D, Rubbia C, Sabaté-Gilarte M, Saxena A, Schillebeeckx P, Schumann D, Sekhar A, Smith AG, Sosnin N, Sprung P, Tagliente G, Tain JL, Tarifeño-Saldivia AE, Thomas B, Torres-Sánchez P, Urlass S, Valenta S, Vannini G, Variale V, Vaz P, Ventura A, Vescovi D, Vlachoudis V, Wallner A, Woods PJ, Wright TJ, Žugec P. First results of the 241Am(n,f) cross section measurement at the Experimental Area 2 of the n_TOF facility at CERN. EPJ Web Conf 2020. [DOI: 10.1051/epjconf/202023905014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Feasibility, design and sensitivity studies on innovative nuclear reactors that could address the issue of nuclear waste transmutation using fuels enriched in minor actinides, require high accuracy cross section data for a variety of neutron-induced reactions from thermal energies to several tens of MeV. The isotope 241Am (T1/2= 433 years) is present in high-level nuclear waste (HLW), representing about 1.8 % of the actinide mass in spent PWR UOx fuel. Its importance increases with cooling time due to additional production from the β-decay of 241Pu with a half-life of 14.3 years. The production rate of 241 Am in conventional reactors, including its further accumulation through the decay of 241Pu and its destruction through transmutation/incineration are very important parameters for the design of any recycling solution. In the present work, the 241 Am(n,f) reaction cross-section was measured using Micromegas detectors at the Experimental Area 2 of the n_TOF facility at CERN. For the measurement, the 235U(n,f) and 238U(n,f) reference reactions were used for the determination of the neutron flux. In the present work an overview of the experimental setup and the adopted data analysis techniques is given along with preliminary results.
Collapse
|
43
|
Holroyd CR, Seth R, Bukhari M, Malaviya A, Holmes C, Curtis E, Chan C, Yusuf MA, Litwic A, Smolen S, Topliffe J, Bennett S, Humphreys J, Green M, Ledingham J. The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis-Executive summary. Rheumatology (Oxford) 2019; 58:220-226. [PMID: 30137623 DOI: 10.1093/rheumatology/key207] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2018] [Indexed: 11/14/2022] Open
Affiliation(s)
- Christopher R Holroyd
- Rheumatology Department, University Hospital Southampton NHS Foundation Trust, Southampton, UK
| | - Rakhi Seth
- Rheumatology Department, University Hospital Southampton NHS Foundation Trust, Southampton, UK
| | - Marwan Bukhari
- Rheumatology Department, University Hospitals of Morecombe Bay NHS Foundation Trust, Lancaster, UK
| | - Anshuman Malaviya
- Rheumatology Department, Mid Essex Hospital NHS Trust, Chelmsford, UK
| | - Claire Holmes
- Rheumatology Department, University Hospital Southampton NHS Foundation Trust, Southampton, UK
| | - Elizabeth Curtis
- MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK
| | - Christopher Chan
- Rheumatology Department, University Hospital Southampton NHS Foundation Trust, Southampton, UK
| | - Mohammed A Yusuf
- Rheumatology Department, Mid Essex Hospital NHS Trust, Chelmsford, UK
| | - Anna Litwic
- MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.,Rheumatology Department, Salisbury District Hospital, Salisbury, UK
| | - Susan Smolen
- Rheumatology Department, Mid Essex Hospital NHS Trust, Chelmsford, UK
| | - Joanne Topliffe
- Rheumatology Department, Mid Essex Hospital NHS Trust, Chelmsford, UK
| | - Sarah Bennett
- Rheumatology Department, University Hospital Southampton NHS Foundation Trust, Southampton, UK
| | - Jennifer Humphreys
- Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, UK
| | - Muriel Green
- National Rheumatoid Arthritis Society, Queen Alexandra Hospital, Portsmouth, UK
| | - Jo Ledingham
- Rheumatology Department, Queen Alexandra Hospital, Portsmouth, UK
| |
Collapse
|
44
|
Abstract
This article draws on life-course and desistance theory to explore the relationship between the factors of age, ethnicity, offence type, and incarceration history for a sample of 1,035 women released from custody between January 2013 and January 2014, data gathered from the Australian Queensland Corrective Services administrative dataset. It also explores their impact on recidivism and the time between release and reoffending (known as "time to failure") until September 2017. The data indicate substantial rates of reoffending with 70% of the sample reoffending (a return to custody/parole/probation) within the 2- to 4-year observation period. Notably, 50% of women reoffended in their first year post-release, 36% within 6 months, and 23% within the first 3 months. Regression results show that violent offenders are considerably more likely to be recidivists and older offenders are less likely to be recidivists; Aboriginal and Torres Strait Islander offenders were also more likely to reoffend. Incarceration history is significantly associated with reoffending and "time to failure". It is clear that there needs to be increased intervention and support for female offenders during the first 2 years post-release from custody. This is particularly important for Aboriginal and Torres Strait Islander women and those with an extensive history of incarceration.
Collapse
Affiliation(s)
| | - Sarah Bennett
- 1 The University of Queensland, St Lucia, Queensland, Australia
| | - Michelle Sydes
- 1 The University of Queensland, St Lucia, Queensland, Australia
| |
Collapse
|
45
|
Luvsansharav UO, Vieira A, Bennett S, Huang J, Healy JM, Hoekstra RM, Bruce BB, Cole D. Salmonella Serotypes: A Novel Measure of Association with Foodborne Transmission. Foodborne Pathog Dis 2019; 17:151-155. [PMID: 31566417 DOI: 10.1089/fpd.2019.2641] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Most nontyphoidal Salmonella (NTS) illnesses in the United States are thought to be foodborne. However, transmission routes likely vary among the different serotypes. We developed a relative ranking of NTS serotypes according to the strength of their association with foodborne transmission. We used Laboratory-based Enteric Disease Surveillance data to estimate the proportion of infections for each Salmonella serotype reported from 1998 to 2015 and Foodborne Disease Outbreak Surveillance System data to calculate the proportion of foodborne outbreak-associated Salmonella illnesses caused by each serotype. We calculated the ratios of these proportions to create a foodborne relatedness (FBR) measure for each serotype. Of the top 20 serotypes, Saintpaul (2.14), Heidelberg (1.61), and Berta (1.48) had the highest FBR measures; Mississippi (0.01), Bareilly (0.13), and Paratyphi B variant L(+) tartrate(+) (0.20) had the lowest. The FBRs for the three most prevalent serotypes were 1.22 for Enteritidis, 0.77 for Typhimurium, and 1.16 for Newport. This method provides a quantitative approach to estimating the relative differences in the likelihood that an illness caused by a particular serotype was transmitted by food, which may aid in tailoring strategies to prevent Salmonella illnesses and guide future research into serotype-specific source attribution.
Collapse
Affiliation(s)
- Ulzii Orshikh Luvsansharav
- Epidemic Intelligence Service, Epidemiology Workforce Branch, Division of Scientific Education and Professional Development, Centers for Disease Control and Prevention, Atlanta, Georgia.,Enteric Diseases Epidemiology Branch, Division of Foodborne, Waterborne and Environmental Diseases, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Antonio Vieira
- Enteric Diseases Epidemiology Branch, Division of Foodborne, Waterborne and Environmental Diseases, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Sarah Bennett
- Enteric Diseases Epidemiology Branch, Division of Foodborne, Waterborne and Environmental Diseases, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Jennifer Huang
- Enteric Diseases Epidemiology Branch, Division of Foodborne, Waterborne and Environmental Diseases, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Jessica Meaghan Healy
- Enteric Diseases Epidemiology Branch, Division of Foodborne, Waterborne and Environmental Diseases, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Robert Michael Hoekstra
- Enteric Diseases Epidemiology Branch, Division of Foodborne, Waterborne and Environmental Diseases, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Beau Benjamin Bruce
- Enteric Diseases Epidemiology Branch, Division of Foodborne, Waterborne and Environmental Diseases, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Dana Cole
- Enteric Diseases Epidemiology Branch, Division of Foodborne, Waterborne and Environmental Diseases, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
| |
Collapse
|
46
|
Harvey RR, Cooper R, Bennett S, Richardson M, Duke D, Stoughton C, Smalligan R, Gaul L, Drenzek C, Griffin PM, Geissler A, Rao AK. Outbreak of Foodborne Botulism in an Immigrant Community: Overcoming Delayed Disease Recognition, Ambiguous Epidemiologic Links, and Cultural Barriers to Identify the Cause. Clin Infect Dis 2019; 66:S82-S84. [PMID: 29293929 DOI: 10.1093/cid/cix817] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
We describe a botulism outbreak involving 4 Middle Eastern men complicated by delayed diagnosis, ambiguous epidemiologic links among patients, and illness onset dates inconsistent with a point-source exposure. Homemade turshi, a fermented vegetable dish, was the likely cause. Patients ate turshi at 2 locations on different days over 1 month.
Collapse
Affiliation(s)
- R Reid Harvey
- Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.,Enteric Diseases Epidemiology Branch, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Robert Cooper
- Texas Tech University Health Sciences Center, Amarillo
| | - Sarah Bennett
- Enteric Diseases Epidemiology Branch, Centers for Disease Control and Prevention, Atlanta, Georgia
| | | | - Deree Duke
- Amarillo Environmental Health Department, Amarillo
| | | | - Roger Smalligan
- Potter and Randall Counties Public Health Authority, Amarillo
| | - Linda Gaul
- Texas Department of State Health Services, Austin
| | | | - Patricia M Griffin
- Enteric Diseases Epidemiology Branch, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Aimee Geissler
- Enteric Diseases Epidemiology Branch, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Agam K Rao
- Enteric Diseases Epidemiology Branch, Centers for Disease Control and Prevention, Atlanta, Georgia
| |
Collapse
|
47
|
Emperador F, Bennett S, Gonzalez J, Saati A, Alsaywid B, Fernandez A. Lung ultrasound (LUS) for the assessment of extravascular lung water (EVLW) and effect on oxygenation in cardiac surgery: a prospective study. J Cardiothorac Vasc Anesth 2019. [DOI: 10.1053/j.jvca.2019.07.081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
48
|
Kanu H, Wilson K, Sesay-Kamara N, Bennett S, Mehtar S, Storr J, Allegranzi B, Benya H, Park B, Kolwaite A. Creation of a national infection prevention and control programme in Sierra Leone, 2015. BMJ Glob Health 2019; 4:e001504. [PMID: 31263590 PMCID: PMC6570974 DOI: 10.1136/bmjgh-2019-001504] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2019] [Revised: 04/01/2019] [Accepted: 04/20/2019] [Indexed: 11/06/2022] Open
Abstract
Prior to the 2014–2016 Ebola epidemic, Sierra Leone’s Ministry of Health and Sanitation had no infection prevention and control programme. High rates of Ebola virus disease transmission in healthcare facilities underscored the need for infection prevention and control in the healthcare system. The Ministry of Health and Sanitation led an effort among international partners to rapidly stand up a national infection prevention and control programme to decrease Ebola transmission in healthcare facilities and strengthen healthcare safety and quality. Leadership and ownership by the Ministry of Health and Sanitation was the catalyst for development of the programme, including the presence of an infection prevention and control champion within the ministry. A national policy and guidelines were drafted and approved to outline organisation and standards for the programme. Infection prevention and control focal persons were identified and embedded at public hospitals to manage implementation. The Ministry of Health and Sanitation and international partners initiated training for new infection prevention and control focal persons and committees. Monitoring systems to track infection prevention and control implementation were also established. This is a novel example of rapid development of a national infection prevention and control programme under challenging conditions. The approach to rapidly develop a national infection prevention and control programme in Sierra Leone may provide useful lessons for other programmes in countries or contexts starting from a low baseline for infection prevention and control.
Collapse
Affiliation(s)
- Hossinatu Kanu
- Sierra Leone Ministry of Health and Sanitation, Freetown, Sierra Leone
| | - Kathryn Wilson
- Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | | | - Sarah Bennett
- Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Shaheen Mehtar
- Infection Control Africa Network, Stellenbosch, South Africa
| | - Julie Storr
- Global Infection Prevention and Control Unit, WHO, Geneva, Switzerland
| | | | - Hassan Benya
- Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Benjamin Park
- Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Amy Kolwaite
- Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| |
Collapse
|
49
|
Scott K, Jessani N, Qiu M, Bennett S. Developing more participatory and accountable institutions for health: identifying health system research priorities for the Sustainable Development Goal-era. Health Policy Plan 2019; 33:975-987. [PMID: 30247610 PMCID: PMC6263024 DOI: 10.1093/heapol/czy079] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/13/2018] [Indexed: 11/13/2022] Open
Abstract
Health policy and systems research (HPSR) is vital to guiding global institutions, funders, policymakers, activists and implementers in developing and enacting strategies to achieve the Sustainable Development Goals. We undertook a multi-stage participatory process to identify priority research questions relevant to improving accountability within health systems. We conducted interviews (n = 54) and focus group discussions (n = 2) with policymakers from international and national bodies (ministries of health, other government agencies and technical support institutions) across the WHO regions. Respondents were asked to reflect on challenges and current policy discussions related to health systems accountability, and to identify their pressing research needs. We also conducted an overview of reviews (n = 34) to determine the current status of knowledge on health systems accountability and to identify any gaps. We extracted research questions from the policymaker interviews and focus groups (70 questions) and from the overview of reviews (112 questions), and synthesized these into 36 overarching questions. Using the online platform Co-Digital, we invited researchers from around the world to refine and then rank the questions according to research importance. The questions that emerged amongst the top priorities focused on political factors that mediate the adoption or effectiveness of accountability initiatives, processes and incentives that facilitate the acceptability of accountability mechanisms among frontline healthcare providers, and the national governance reforms and contexts that enhance provider accountability. The process revealed different underlying conceptions of social accountability and how best to promote it, with some researchers and policymakers focusing on specific interventions and others embracing a more systems-oriented approach to understanding accountability, the multiple forms that it can take, how these interact with each other and the importance of power and underlying social relations. The findings from this exercise identify HPSR funding priorities and future areas for evidence production and policy engagement.
Collapse
Affiliation(s)
- K Scott
- Health Systems Program, Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolf Street, Baltimore, MA, USA
| | - N Jessani
- Department of Health Behavior and Society, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolf Street, Baltimore, MA, USA
| | - M Qiu
- Health Systems Program, Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolf Street, Baltimore, MA, USA
| | - S Bennett
- Health Systems Program, Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolf Street, Baltimore, MA, USA
| |
Collapse
|
50
|
Denning D, Bennett S, Mullen T, Moyer C, Vorselen D, Wuite GJL, Nemerow G, Roos WH. Maturation of adenovirus primes the protein nano-shell for successful endosomal escape. Nanoscale 2019; 11:4015-4024. [PMID: 30768112 DOI: 10.1039/c8nr10182e] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
The ability of adenoviruses to infect a broad range of species has spurred a growing interest in nanomedicine to use adenovirus as a cargo delivery vehicle. While successful maturation of adenovirus and controlled disassembly are critical for efficient infection, the underlying mechanisms regulating these processes are not well understood. Here, we present Atomic Force Microscopy nanoindentation and fatigue studies of adenovirus capsids at different maturation stages to scrutinize their dynamic uncoating properties. Surprisingly, we find that the early intermediate immature (lacking DNA) capsid is mechanically indistinguishable in both break force and spring constant from the mature (containing DNA) capsid. However, mature and immature capsids do display distinct disassembly pathways, as revealed by our mechanically-induced fatigue analysis. The mature capsid first loses the pentons, followed by either long-term capsid stability or abrupt and complete disassembly. However, the immature capsid has a stable penton region and undergoes a stochastic disassembly mechanism, thought to be due to the absence of genomic pressure. Strikingly, the addition of the genome alone is not sufficient to achieve penton destabilization as indicated by the penton stability of the maturation-intermediate mutant, G33A. Full penton destabilization was achieved only when the genome was present in addition to the successful maturation-linked proteolytic cleavage of preprotein VI. Therefore these findings strongly indicate that maturation of adenovirus in concert with genomic pressure induces penton destabilization and thus, primes the capsid for controlled disassembly. This latter aspect is critical for efficient infection and successful cargo delivery.
Collapse
Affiliation(s)
- D Denning
- Moleculaire Biofysica, Zernike Instituut, Rijksuniversiteit Groningen, The Netherlands and Natuur- en Sterrenkunde and LaserLaB, Vrije Universiteit Amsterdam, The Netherlands.
| | - S Bennett
- Department of Immunology and Microbiology, the Scripps Research Institute, La Jolla, CA 92037, USA.
| | - T Mullen
- Department of Immunology and Microbiology, the Scripps Research Institute, La Jolla, CA 92037, USA.
| | - C Moyer
- Department of Immunology and Microbiology, the Scripps Research Institute, La Jolla, CA 92037, USA.
| | - D Vorselen
- Natuur- en Sterrenkunde and LaserLaB, Vrije Universiteit Amsterdam, The Netherlands.
| | - G J L Wuite
- Natuur- en Sterrenkunde and LaserLaB, Vrije Universiteit Amsterdam, The Netherlands.
| | - G Nemerow
- Department of Immunology and Microbiology, the Scripps Research Institute, La Jolla, CA 92037, USA.
| | - W H Roos
- Moleculaire Biofysica, Zernike Instituut, Rijksuniversiteit Groningen, The Netherlands
| |
Collapse
|